| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.788 | 0.002 | 0.788 | Nav1.1 sodium channel blocker | 0.602 0.003 DBMET01193 0.677 0.003 DBMET01194 0.303 0.008 DBMET01195 0.677 0.003 DBMET01196 0.478 0.004 DBMET01631 | ||
| 0.779 | 0.004 | 0.782 | Vasodilator, peripheral | 0.672 0.008 DBMET01193 0.782 0.004 DBMET01194 0.37 0.065 DBMET01195 0.782 0.004 DBMET01196 0.262 0.118 DBMET01630 0.678 0.008 DBMET01631 | DBMET01196 | |
| 0.66 | 0.018 | 0.741 | Analgesic | 0.741 0.01 DBMET01193 0.567 0.033 DBMET01194 0.234 0.198 DBMET01195 0.567 0.033 DBMET01196 | DBMET01193 | |
| 0.636 | 0.012 | 0.636 | Thioredoxin glutathione reductase inhibitor | 0.55 0.021 DBMET01193 0.549 0.021 DBMET01194 0.245 0.137 DBMET01195 0.549 0.021 DBMET01196 | ||
| 0.59 | 0.014 | 0.628 | Spasmolytic | 0.433 0.034 DBMET01193 0.628 0.01 DBMET01194 0.278 0.079 DBMET01195 0.628 0.01 DBMET01196 0.406 0.039 DBMET01631 | DBMET01196 | |
| 0.566 | 0.005 | 0.586 | Sigma receptor agonist | 0.526 0.008 DBMET01194 0.526 0.008 DBMET01196 0.346 0.031 DBMET01630 0.586 0.005 DBMET01631 | DBMET01631 | |
| 0.561 | 0.003 | 0.652 | Ca(v)2.2 blocker | 0.652 0.003 DBMET01193 0.394 0.004 DBMET01194 0.394 0.004 DBMET01196 | DBMET01193 | |
| 0.555 | 0.008 | 0.555 | Vasodilator | 0.479 0.014 DBMET01193 0.517 0.011 DBMET01194 0.517 0.011 DBMET01196 0.23 0.083 DBMET01630 0.332 0.038 DBMET01631 | ||
| 0.508 | 0.026 | 0.56 | Histamine release inhibitor | 0.5 0.029 DBMET01193 0.56 0.015 DBMET01194 0.427 0.062 DBMET01195 0.56 0.015 DBMET01196 0.356 0.097 DBMET01630 0.314 0.116 DBMET01631 | DBMET01196 | |
| 0.476 | 0.004 | 0.476 | Analgesic, opioid | 0.426 0.004 DBMET01193 0.445 0.004 DBMET01194 0.445 0.004 DBMET01196 0.095 0.034 DBMET01631 | ||
| 0.468 | 0.004 | 0.468 | Nav1.3 sodium channel blocker | 0.32 0.008 DBMET01193 0.37 0.005 DBMET01194 0.122 0.071 DBMET01195 0.37 0.005 DBMET01196 0.226 0.018 DBMET01631 | ||
| 0.449 | 0.003 | 0.449 | Calcium antagonist | 0.294 0.005 DBMET01193 0.308 0.004 DBMET01194 0.154 0.021 DBMET01195 0.308 0.004 DBMET01196 0.107 0.043 DBMET01630 0.302 0.005 DBMET01631 | ||
| 0.458 | 0.022 | 0.466 | Vasodilator, coronary | 0.436 0.026 DBMET01193 0.466 0.021 DBMET01194 0.428 0.028 DBMET01195 0.466 0.021 DBMET01196 0.281 0.104 DBMET01630 0.391 0.038 DBMET01631 | DBMET01196 | |
| 0.434 | 0.008 | 0.473 | Lipid peroxidase inhibitor | 0.285 0.021 DBMET01193 0.473 0.006 DBMET01194 0.473 0.006 DBMET01196 0.219 0.034 DBMET01631 | DBMET01196 | |
| 0.42 | 0.005 | 0.42 | Calcium channel blocker | 0.278 0.012 DBMET01193 0.296 0.01 DBMET01194 0.296 0.01 DBMET01196 0.196 0.032 DBMET01631 | ||
| 0.408 | 0.004 | 0.408 | Alpha 2c adrenoreceptor antagonist | 0.271 0.008 DBMET01193 0.358 0.005 DBMET01194 0.358 0.005 DBMET01196 0.393 0.004 DBMET01631 | ||
| 0.407 | 0.026 | 0.702 | Superoxide dismutase inhibitor | 0.422 0.023 DBMET01193 0.487 0.014 DBMET01194 0.53 0.01 DBMET01195 0.487 0.014 DBMET01196 0.702 0.004 DBMET01630 0.697 0.004 DBMET01631 | DBMET01630 | |
| 0.386 | 0.005 | 0.386 | Alpha 2b adrenoreceptor antagonist | 0.354 0.006 DBMET01193 0.338 0.007 DBMET01194 0.112 0.065 DBMET01195 0.338 0.007 DBMET01196 0.38 0.005 DBMET01631 | ||
| 0.374 | 0.008 | 0.374 | Nav1.2 sodium channel blocker | 0.349 0.01 DBMET01193 0.318 0.013 DBMET01194 0.11 0.096 DBMET01195 0.318 0.013 DBMET01196 0.213 0.03 DBMET01631 | ||
| 0.368 | 0.005 | 0.368 | Calcium channel (voltage-sensitive) blocker | 0.215 0.014 DBMET01193 0.233 0.012 DBMET01194 0.233 0.012 DBMET01196 0.144 0.037 DBMET01631 | ||
| 0.366 | 0.004 | 0.366 | Nav1.6 sodium channel blocker | 0.301 0.006 DBMET01193 0.288 0.006 DBMET01194 0.146 0.059 DBMET01195 0.288 0.006 DBMET01196 0.193 0.022 DBMET01631 | ||
| 0.362 | 0.004 | 0.375 | Opioid delta receptor antagonist | 0.301 0.005 DBMET01193 0.375 0.004 DBMET01194 0.375 0.004 DBMET01196 0.074 0.039 DBMET01631 | DBMET01196 | |
| 0.362 | 0.005 | 0.379 | Opioid antagonist | 0.263 0.007 DBMET01193 0.379 0.005 DBMET01194 0.379 0.005 DBMET01196 0.104 0.045 DBMET01631 | DBMET01196 | |
| 0.356 | 0.014 | 0.543 | Phospholipase C inhibitor | 0.543 0.005 DBMET01193 0.453 0.008 DBMET01194 0.193 0.049 DBMET01195 0.453 0.008 DBMET01196 0.2 0.043 DBMET01630 0.23 0.03 DBMET01631 | DBMET01193 | |
| 0.375 | 0.033 | 0.465 | Cardiotonic | 0.465 0.019 DBMET01193 0.284 0.063 DBMET01194 0.401 0.029 DBMET01195 0.284 0.063 DBMET01196 | DBMET01193 | |
| 0.342 | 0.004 | 0.342 | Calcium channel N-type blocker | 0.225 0.012 DBMET01193 0.243 0.009 DBMET01194 0.243 0.009 DBMET01196 0.173 0.025 DBMET01631 | ||
| 0.318 | 0.013 | 0.355 | Insulin sensitizer | 0.236 0.043 DBMET01193 0.355 0.009 DBMET01194 0.262 0.028 DBMET01195 0.355 0.009 DBMET01196 0.177 0.099 DBMET01630 0.207 0.067 DBMET01631 | DBMET01196 | |
| 0.403 | 0.098 | 0.527 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.494 0.036 DBMET01193 0.281 0.24 DBMET01194 0.527 0.023 DBMET01195 0.281 0.24 DBMET01196 0.437 0.07 DBMET01630 0.479 0.044 DBMET01631 | DBMET01195 | |
| 0.308 | 0.016 | 0.308 | Neuropeptide Y2 antagonist | 0.295 0.021 DBMET01193 0.308 0.016 DBMET01194 0.224 0.083 DBMET01195 0.308 0.016 DBMET01196 0.234 0.073 DBMET01630 0.245 0.062 DBMET01631 | ||
| 0.296 | 0.004 | 0.316 | Opioid agonist | 0.316 0.004 DBMET01193 0.29 0.004 DBMET01194 0.29 0.004 DBMET01196 | DBMET01193 | |
| 0.293 | 0.005 | 0.317 | Opioid kappa receptor antagonist | 0.177 0.013 DBMET01193 0.317 0.005 DBMET01194 0.317 0.005 DBMET01196 0.089 0.046 DBMET01631 | DBMET01196 | |
| 0.289 | 0.007 | 0.289 | Histamine H1 receptor antagonist | 0.236 0.011 DBMET01193 0.18 0.017 DBMET01194 0.075 0.062 DBMET01195 0.18 0.017 DBMET01196 0.112 0.035 DBMET01631 | ||
| 0.285 | 0.005 | 0.285 | Dopamine D4 agonist | 0.276 0.005 DBMET01193 0.13 0.011 DBMET01194 0.13 0.011 DBMET01196 0.062 0.026 DBMET01631 | ||
| 0.283 | 0.007 | 0.367 | Alpha 2a adrenoreceptor antagonist | 0.291 0.007 DBMET01193 0.262 0.009 DBMET01194 0.262 0.009 DBMET01196 0.367 0.005 DBMET01631 | DBMET01631 | |
| 0.281 | 0.011 | 0.326 | Antihistaminic | 0.326 0.009 DBMET01193 0.132 0.038 DBMET01194 0.132 0.038 DBMET01196 0.115 0.045 DBMET01631 | DBMET01193 | |
| 0.271 | 0.004 | 0.271 | Calcium channel L-type blocker | 0.152 0.01 DBMET01193 0.193 0.006 DBMET01194 0.083 0.036 DBMET01195 0.193 0.006 DBMET01196 0.122 0.015 DBMET01631 | ||
| 0.284 | 0.017 | 0.284 | Acetylcholine M1 receptor antagonist | 0.274 0.02 DBMET01193 0.281 0.018 DBMET01194 0.151 0.073 DBMET01195 0.281 0.018 DBMET01196 0.277 0.019 DBMET01631 | ||
| 0.264 | 0.004 | 0.329 | Opioid delta receptor agonist | 0.329 0.004 DBMET01193 0.259 0.004 DBMET01194 0.259 0.004 DBMET01196 0.032 0.031 DBMET01631 | DBMET01193 | |
| 0.27 | 0.012 | 0.316 | Histamine antagonist | 0.316 0.009 DBMET01193 0.115 0.04 DBMET01194 0.115 0.04 DBMET01196 0.104 0.045 DBMET01631 | DBMET01193 | |
| 0.267 | 0.01 | 0.294 | ATPase inhibitor | 0.203 0.035 DBMET01193 0.273 0.009 DBMET01194 0.246 0.015 DBMET01195 0.273 0.009 DBMET01196 0.294 0.007 DBMET01630 0.188 0.049 DBMET01631 | DBMET01630 | |
| 0.344 | 0.089 | 0.596 | GABA C receptor rho-3 antagonist | 0.464 0.037 DBMET01193 0.381 0.07 DBMET01194 0.596 0.008 DBMET01195 0.381 0.07 DBMET01196 0.476 0.033 DBMET01630 0.468 0.035 DBMET01631 | DBMET01195 | |
| 0.323 | 0.07 | 0.422 | Apoptosis antagonist | 0.289 0.093 DBMET01193 0.354 0.054 DBMET01194 0.354 0.054 DBMET01196 0.422 0.033 DBMET01630 | DBMET01630 | |
| 0.262 | 0.012 | 0.297 | 5 Hydroxytryptamine 3E antagonist | 0.261 0.012 DBMET01193 0.212 0.045 DBMET01194 0.279 0.008 DBMET01195 0.212 0.045 DBMET01196 0.267 0.01 DBMET01630 0.297 0.005 DBMET01631 | DBMET01631 | |
| 0.259 | 0.022 | 0.259 | Antipruritic | 0.256 0.023 DBMET01193 0.246 0.026 DBMET01194 0.129 0.125 DBMET01195 0.246 0.026 DBMET01196 0.163 0.08 DBMET01631 | ||
| 0.24 | 0.008 | 0.24 | Dopamine D3 antagonist | 0.119 0.02 DBMET01193 0.199 0.011 DBMET01194 0.199 0.011 DBMET01196 0.148 0.015 DBMET01631 | ||
| 0.241 | 0.012 | 0.332 | Alpha 2 adrenoreceptor antagonist | 0.258 0.011 DBMET01193 0.21 0.016 DBMET01194 0.21 0.016 DBMET01196 0.332 0.007 DBMET01631 | DBMET01631 | |
| 0.245 | 0.019 | 0.317 | 5 Hydroxytryptamine 2B antagonist | 0.317 0.013 DBMET01193 0.171 0.033 DBMET01194 0.115 0.065 DBMET01195 0.171 0.033 DBMET01196 0.226 0.022 DBMET01631 | DBMET01193 | |
| 0.234 | 0.011 | 0.322 | Mediator release inhibitor | 0.149 0.029 DBMET01193 0.322 0.006 DBMET01194 0.322 0.006 DBMET01196 0.089 0.083 DBMET01631 | DBMET01196 | |
| 0.296 | 0.073 | 0.437 | Lipoxygenase inhibitor | 0.182 0.16 DBMET01193 0.437 0.029 DBMET01194 0.29 0.076 DBMET01195 0.437 0.029 DBMET01196 0.23 0.114 DBMET01630 | DBMET01196 | |
| 0.301 | 0.079 | 0.429 | 12-Lipoxygenase inhibitor | 0.185 0.168 DBMET01193 0.429 0.033 DBMET01194 0.314 0.072 DBMET01195 0.429 0.033 DBMET01196 0.217 0.133 DBMET01630 0.235 0.118 DBMET01631 | DBMET01196 | |
| 0.237 | 0.015 | 0.527 | Neurotrophic factor | 0.245 0.013 DBMET01193 0.21 0.023 DBMET01194 0.21 0.023 DBMET01196 0.527 0.003 DBMET01630 | DBMET01630 | |
| 0.283 | 0.062 | 0.31 | Transcription factor STAT3 inhibitor | 0.21 0.121 DBMET01193 0.31 0.048 DBMET01194 0.249 0.084 DBMET01195 0.31 0.048 DBMET01196 0.306 0.051 DBMET01630 0.22 0.111 DBMET01631 | DBMET01196 | |
| 0.281 | 0.067 | 0.312 | Transcription factor STAT inhibitor | 0.212 0.122 DBMET01193 0.312 0.049 DBMET01194 0.237 0.096 DBMET01195 0.312 0.049 DBMET01196 0.294 0.059 DBMET01630 0.242 0.092 DBMET01631 | DBMET01196 | |
| 0.266 | 0.057 | 0.339 | 5 Hydroxytryptamine 1E antagonist | 0.274 0.051 DBMET01193 0.258 0.066 DBMET01194 0.261 0.063 DBMET01195 0.258 0.066 DBMET01196 0.264 0.059 DBMET01630 0.339 0.013 DBMET01631 | DBMET01631 | |
| 0.216 | 0.007 | 0.254 | Opioid mu receptor antagonist | 0.148 0.018 DBMET01193 0.254 0.005 DBMET01194 0.254 0.005 DBMET01196 0.064 0.05 DBMET01631 | DBMET01196 | |
| 0.276 | 0.071 | 0.546 | Antioxidant | 0.42 0.032 DBMET01194 0.267 0.075 DBMET01195 0.42 0.032 DBMET01196 0.546 0.015 DBMET01630 0.19 0.122 DBMET01631 | DBMET01630 | |
| 0.295 | 0.091 | 0.349 | Antithrombotic | 0.251 0.125 DBMET01193 0.311 0.081 DBMET01194 0.349 0.065 DBMET01195 0.311 0.081 DBMET01196 0.312 0.081 DBMET01630 0.326 0.074 DBMET01631 | DBMET01195 | |
| 0.209 | 0.009 | 0.21 | Dopamine agonist | 0.158 0.014 DBMET01193 0.21 0.009 DBMET01194 0.21 0.009 DBMET01196 0.126 0.019 DBMET01631 | DBMET01196 | |
| 0.204 | 0.006 | 0.204 | Dopamine uptake inhibitor | 0.15 0.01 DBMET01193 0.152 0.01 DBMET01194 0.068 0.032 DBMET01195 0.152 0.01 DBMET01196 0.204 0.006 DBMET01631 | ||
| 0.25 | 0.057 | 0.25 | Anticonvulsant | 0.213 0.074 DBMET01193 0.143 0.138 DBMET01194 0.205 0.079 DBMET01195 0.143 0.138 DBMET01196 0.24 0.061 DBMET01631 | ||
| 0.194 | 0.004 | 0.289 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.174 0.004 DBMET01193 0.289 0.003 DBMET01194 0.086 0.015 DBMET01195 0.289 0.003 DBMET01196 0.089 0.014 DBMET01631 | DBMET01196 | |
| 0.268 | 0.081 | 0.597 | 5 Hydroxytryptamine release stimulant | 0.597 0.015 DBMET01193 0.281 0.076 DBMET01194 0.566 0.018 DBMET01195 0.281 0.076 DBMET01196 0.298 0.071 DBMET01630 0.52 0.024 DBMET01631 | DBMET01193 | |
| 0.289 | 0.103 | 0.512 | Calcium channel activator | 0.382 0.032 DBMET01193 0.275 0.118 DBMET01194 0.512 0.004 DBMET01195 0.275 0.118 DBMET01196 0.325 0.069 DBMET01630 0.438 0.014 DBMET01631 | DBMET01195 | |
| 0.251 | 0.067 | 0.407 | Tyrosine 3 hydroxylase inhibitor | 0.336 0.019 DBMET01193 0.312 0.028 DBMET01194 0.407 0.007 DBMET01195 0.312 0.028 DBMET01196 0.295 0.035 DBMET01630 0.29 0.038 DBMET01631 | DBMET01195 | |
| 0.187 | 0.005 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.186 0.005 DBMET01193 0.184 0.005 DBMET01194 0.184 0.005 DBMET01195 0.184 0.005 DBMET01196 0.166 0.016 DBMET01630 0.159 0.025 DBMET01631 | ||
| 0.179 | 0.005 | 0.179 | Calcium channel T-type blocker | 0.151 0.006 DBMET01193 0.109 0.013 DBMET01194 0.109 0.013 DBMET01196 0.069 0.028 DBMET01631 | ||
| 0.183 | 0.012 | 0.424 | 5 Hydroxytryptamine uptake inhibitor | 0.153 0.015 DBMET01193 0.08 0.034 DBMET01194 0.08 0.034 DBMET01196 0.424 0.005 DBMET01631 | DBMET01631 | |
| 0.177 | 0.006 | 0.192 | Acetylcholine release stimulant | 0.185 0.005 DBMET01193 0.142 0.022 DBMET01194 0.192 0.005 DBMET01195 0.142 0.022 DBMET01196 0.123 0.043 DBMET01630 0.135 0.028 DBMET01631 | DBMET01195 | |
| 0.331 | 0.162 | 0.518 | Caspase 9 stimulant | 0.364 0.135 DBMET01193 0.397 0.113 DBMET01194 0.512 0.055 DBMET01195 0.397 0.113 DBMET01196 0.483 0.067 DBMET01630 0.518 0.053 DBMET01631 | DBMET01631 | |
| 0.266 | 0.099 | 0.906 | Caspase 3 stimulant | 0.345 0.06 DBMET01194 0.191 0.184 DBMET01195 0.345 0.06 DBMET01196 0.906 0.002 DBMET01630 0.218 0.145 DBMET01631 | DBMET01630 | |
| 0.228 | 0.065 | 0.367 | Amyloid beta aggregation inhibitor | 0.367 0.03 DBMET01194 0.177 0.091 DBMET01195 0.367 0.03 DBMET01196 0.218 0.069 DBMET01630 0.274 0.051 DBMET01631 | DBMET01196 | |
| 0.212 | 0.057 | 0.335 | P-glycoprotein inhibitor | 0.209 0.058 DBMET01194 0.335 0.023 DBMET01195 0.209 0.058 DBMET01196 0.189 0.072 DBMET01631 | DBMET01195 | |
| 0.252 | 0.099 | 0.373 | Hypoxia-inducible factor 1 alpha inhibitor | 0.373 0.038 DBMET01193 0.335 0.05 DBMET01194 0.325 0.054 DBMET01195 0.335 0.05 DBMET01196 0.206 0.145 DBMET01630 0.23 0.119 DBMET01631 | DBMET01193 | |
| 0.155 | 0.01 | 0.16 | Lanosterol 14 alpha demethylase inhibitor | 0.16 0.009 DBMET01193 0.148 0.012 DBMET01194 0.128 0.023 DBMET01195 0.148 0.012 DBMET01196 0.111 0.041 DBMET01630 0.115 0.036 DBMET01631 | DBMET01193 | |
| 0.235 | 0.09 | 0.392 | Interleukin agonist | 0.279 0.06 DBMET01193 0.223 0.1 DBMET01194 0.392 0.02 DBMET01195 0.223 0.1 DBMET01196 0.225 0.098 DBMET01630 0.319 0.039 DBMET01631 | DBMET01195 | |
| 0.224 | 0.081 | 0.583 | Free radical scavenger | 0.397 0.029 DBMET01194 0.262 0.063 DBMET01195 0.397 0.029 DBMET01196 0.583 0.009 DBMET01630 0.191 0.105 DBMET01631 | DBMET01630 | |
| 0.276 | 0.134 | 0.593 | Antiobesity | 0.593 0.021 DBMET01193 | DBMET01193 | |
| 0.218 | 0.078 | 0.247 | MAP kinase kinase 3 inhibitor | 0.188 0.16 DBMET01195 0.221 0.073 DBMET01630 0.247 0.034 DBMET01631 | DBMET01631 | |
| 0.305 | 0.169 | 0.87 | Apoptosis agonist | 0.403 0.112 DBMET01194 0.363 0.132 DBMET01195 0.403 0.112 DBMET01196 0.87 0.009 DBMET01630 0.326 0.155 DBMET01631 | DBMET01630 | |
| 0.175 | 0.039 | 0.175 | Anesthetic local | 0.158 0.045 DBMET01193 0.15 0.049 DBMET01194 0.167 0.042 DBMET01195 0.15 0.049 DBMET01196 0.099 0.084 DBMET01630 0.107 0.076 DBMET01631 | ||
| 0.143 | 0.008 | 0.145 | Acetylcholine M5 receptor antagonist | 0.145 0.008 DBMET01193 0.123 0.012 DBMET01194 0.059 0.043 DBMET01195 0.123 0.012 DBMET01196 0.108 0.015 DBMET01631 | DBMET01193 | |
| 0.216 | 0.081 | 0.336 | HERG channel blocker | 0.336 0.041 DBMET01193 0.237 0.072 DBMET01631 | DBMET01193 | |
| 0.278 | 0.144 | 0.403 | 15-Lipoxygenase inhibitor | 0.222 0.19 DBMET01193 0.403 0.073 DBMET01194 0.391 0.078 DBMET01195 0.403 0.073 DBMET01196 | DBMET01196 | |
| 0.142 | 0.012 | 0.172 | Acetylcholine M4 receptor antagonist | 0.172 0.008 DBMET01193 0.091 0.036 DBMET01194 0.084 0.042 DBMET01195 0.091 0.036 DBMET01196 0.121 0.017 DBMET01631 | DBMET01193 | |
| 0.164 | 0.04 | 0.238 | 5 Hydroxytryptamine 2 antagonist | 0.238 0.023 DBMET01193 0.1 0.072 DBMET01194 0.094 0.076 DBMET01195 0.1 0.072 DBMET01196 0.208 0.029 DBMET01631 | DBMET01193 | |
| 0.149 | 0.026 | 0.149 | Dopamine antagonist | 0.104 0.037 DBMET01193 0.138 0.028 DBMET01194 0.138 0.028 DBMET01196 0.147 0.026 DBMET01631 | ||
| 0.126 | 0.003 | 0.126 | GABA uptake inhibitor | 0.102 0.004 DBMET01193 0.113 0.003 DBMET01194 0.058 0.011 DBMET01195 0.113 0.003 DBMET01196 0.079 0.005 DBMET01630 0.074 0.006 DBMET01631 | ||
| 0.156 | 0.036 | 0.535 | Interleukin 1b antagonist | 0.129 0.056 DBMET01194 0.535 0.004 DBMET01195 0.129 0.056 DBMET01196 0.374 0.005 DBMET01630 0.261 0.011 DBMET01631 | DBMET01195 | |
| 0.168 | 0.049 | 0.174 | Cell wall synthesis inhibitor | 0.154 0.062 DBMET01193 0.174 0.044 DBMET01194 0.157 0.059 DBMET01195 0.174 0.044 DBMET01196 0.165 0.052 DBMET01631 | DBMET01196 | |
| 0.126 | 0.008 | 0.136 | Dopamine transporter inhibitor | 0.102 0.011 DBMET01193 0.087 0.015 DBMET01194 0.087 0.015 DBMET01196 0.136 0.007 DBMET01631 | DBMET01631 | |
| 0.165 | 0.047 | 0.552 | Alpha-N-acetylglucosaminidase inhibitor | 0.319 0.014 DBMET01193 0.127 0.071 DBMET01194 0.514 0.005 DBMET01195 0.127 0.071 DBMET01196 0.552 0.004 DBMET01630 0.182 0.04 DBMET01631 | DBMET01630 | |
| 0.144 | 0.028 | 0.144 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 DBMET01193 0.136 0.034 DBMET01194 0.111 0.06 DBMET01195 0.136 0.034 DBMET01196 | ||
| 0.173 | 0.058 | 0.205 | Phospholipase A2 inhibitor | 0.126 0.107 DBMET01193 0.205 0.04 DBMET01194 0.197 0.044 DBMET01195 0.205 0.04 DBMET01196 0.145 0.08 DBMET01630 | DBMET01196 | |
| 0.162 | 0.048 | 0.162 | Acetylcholinesterase inhibitor | 0.148 0.056 DBMET01194 0.107 0.094 DBMET01195 0.148 0.056 DBMET01196 0.134 0.066 DBMET01631 | ||
| 0.154 | 0.043 | 0.204 | Cholesterol synthesis inhibitor | 0.193 0.028 DBMET01194 0.134 0.054 DBMET01195 0.193 0.028 DBMET01196 0.204 0.026 DBMET01630 0.159 0.04 DBMET01631 | DBMET01630 | |
| 0.137 | 0.028 | 0.172 | Prolactin inhibitor | 0.122 0.037 DBMET01193 0.172 0.015 DBMET01194 0.156 0.02 DBMET01195 0.172 0.015 DBMET01196 0.156 0.02 DBMET01630 0.171 0.015 DBMET01631 | DBMET01196 | |
| 0.133 | 0.026 | 0.186 | Alpha 1b adrenoreceptor antagonist | 0.186 0.016 DBMET01193 0.104 0.034 DBMET01194 0.104 0.034 DBMET01196 0.126 0.028 DBMET01631 | DBMET01193 | |
| 0.222 | 0.115 | 0.458 | 5 Hydroxytryptamine uptake stimulant | 0.438 0.009 DBMET01193 0.218 0.121 DBMET01194 0.458 0.006 DBMET01195 0.218 0.121 DBMET01196 0.278 0.058 DBMET01630 0.301 0.044 DBMET01631 | DBMET01195 | |
| 0.175 | 0.074 | 0.421 | Succinate dehydrogenase inhibitor | 0.161 0.094 DBMET01193 0.185 0.063 DBMET01194 0.302 0.01 DBMET01195 0.185 0.063 DBMET01196 0.421 0.004 DBMET01630 0.192 0.056 DBMET01631 | DBMET01630 | |
| 0.147 | 0.046 | 0.173 | Acetylcholine muscarinic antagonist | 0.168 0.035 DBMET01193 0.147 0.046 DBMET01194 0.101 0.089 DBMET01195 0.147 0.046 DBMET01196 0.173 0.033 DBMET01631 | DBMET01631 | |
| 0.141 | 0.041 | 0.218 | 5-Lipoxygenase inhibitor | 0.218 0.021 DBMET01194 0.117 0.051 DBMET01195 0.218 0.021 DBMET01196 0.171 0.031 DBMET01630 | DBMET01196 | |
| 0.104 | 0.004 | 0.149 | Nociceptin (N/OFQ) receptor agonist | 0.149 0.003 DBMET01193 0.054 0.005 DBMET01194 0.054 0.005 DBMET01196 | DBMET01193 | |
| 0.135 | 0.038 | 0.172 | Nav1.5 sodium channel blocker | 0.172 0.019 DBMET01193 0.104 0.077 DBMET01194 0.14 0.034 DBMET01195 0.104 0.077 DBMET01196 | DBMET01193 | |
| 0.139 | 0.044 | 0.167 | Sphingosine 1-phosphate receptor 4 antagonist | 0.132 0.053 DBMET01193 0.125 0.063 DBMET01194 0.167 0.02 DBMET01195 0.125 0.063 DBMET01196 0.136 0.048 DBMET01630 0.117 0.078 DBMET01631 | DBMET01195 | |
| 0.122 | 0.027 | 0.127 | Dopamine D2 antagonist | 0.088 0.036 DBMET01193 0.114 0.029 DBMET01194 0.114 0.029 DBMET01196 0.127 0.026 DBMET01631 | DBMET01631 | |
| 0.118 | 0.022 | 0.126 | Cannabinoid receptor antagonist | 0.126 0.02 DBMET01193 0.067 0.053 DBMET01194 0.121 0.021 DBMET01195 0.067 0.053 DBMET01196 | DBMET01193 | |
| 0.107 | 0.017 | 0.115 | Ca(v)3.1 blocker | 0.115 0.012 DBMET01193 0.097 0.026 DBMET01194 0.097 0.026 DBMET01196 | DBMET01193 | |
| 0.099 | 0.01 | 0.099 | Potassium channel (Tandem pore domain) blocker | 0.097 0.011 DBMET01193 0.076 0.044 DBMET01194 0.084 0.026 DBMET01195 0.076 0.044 DBMET01196 0.076 0.046 DBMET01631 | ||
| 0.104 | 0.016 | 0.147 | Sigma receptor antagonist | 0.069 0.024 DBMET01194 0.069 0.024 DBMET01196 0.147 0.011 DBMET01631 | DBMET01631 | |
| 0.11 | 0.022 | 0.183 | Dopamine D1 antagonist | 0.077 0.034 DBMET01193 0.183 0.012 DBMET01194 0.064 0.045 DBMET01195 0.183 0.012 DBMET01196 0.154 0.014 DBMET01631 | DBMET01196 | |
| 0.13 | 0.043 | 0.416 | GABA C receptor agonist | 0.339 0.007 DBMET01193 0.109 0.058 DBMET01194 0.416 0.005 DBMET01195 0.109 0.058 DBMET01196 0.251 0.013 DBMET01630 0.25 0.013 DBMET01631 | DBMET01195 | |
| 0.101 | 0.016 | 0.115 | Cannabinoid CB1 receptor antagonist | 0.115 0.012 DBMET01193 0.062 0.042 DBMET01194 0.104 0.015 DBMET01195 0.062 0.042 DBMET01196 | DBMET01193 | |
| 0.122 | 0.037 | 0.171 | 5 Hydroxytryptamine 2A antagonist | 0.171 0.024 DBMET01193 0.069 0.068 DBMET01194 0.072 0.065 DBMET01195 0.069 0.068 DBMET01196 0.162 0.025 DBMET01631 | DBMET01193 | |
| 0.16 | 0.077 | 0.231 | Heat shock protein 90 alpha antagonist | 0.185 0.059 DBMET01193 0.231 0.034 DBMET01194 0.178 0.064 DBMET01195 0.231 0.034 DBMET01196 0.125 0.118 DBMET01630 | DBMET01196 | |
| 0.097 | 0.014 | 0.097 | Melanin-concentrating hormone receptor 1 antagonist | 0.047 0.044 DBMET01193 0.072 0.023 DBMET01631 | ||
| 0.112 | 0.032 | 0.155 | Alpha 2d adrenoreceptor antagonist | 0.098 0.051 DBMET01193 0.092 0.064 DBMET01194 0.092 0.064 DBMET01196 0.155 0.008 DBMET01631 | DBMET01631 | |
| 0.117 | 0.037 | 0.181 | 5 Hydroxytryptamine 2C antagonist | 0.181 0.02 DBMET01193 0.072 0.07 DBMET01194 0.077 0.064 DBMET01195 0.072 0.07 DBMET01196 0.174 0.021 DBMET01631 | DBMET01193 | |
| 0.137 | 0.06 | 0.188 | Cholinergic antagonist | 0.188 0.035 DBMET01193 0.128 0.066 DBMET01194 0.128 0.066 DBMET01196 0.184 0.037 DBMET01631 | DBMET01193 | |
| 0.122 | 0.046 | 0.229 | Alpha adrenoreceptor antagonist | 0.155 0.036 DBMET01193 0.096 0.059 DBMET01194 0.096 0.059 DBMET01196 0.229 0.023 DBMET01631 | DBMET01631 | |
| 0.12 | 0.045 | 0.32 | Antiadrenergic | 0.183 0.028 DBMET01193 0.103 0.054 DBMET01194 0.103 0.054 DBMET01196 0.32 0.012 DBMET01631 | DBMET01631 | |
| 0.08 | 0.008 | 0.104 | Adenylate cyclase 1 inhibitor | 0.072 0.011 DBMET01194 0.086 0.006 DBMET01195 0.072 0.011 DBMET01196 0.08 0.008 DBMET01630 0.104 0.004 DBMET01631 | DBMET01631 | |
| 0.116 | 0.045 | 0.317 | Adrenaline antagonist | 0.181 0.027 DBMET01193 0.1 0.054 DBMET01194 0.1 0.054 DBMET01196 0.317 0.012 DBMET01631 | DBMET01631 | |
| 0.082 | 0.013 | 0.105 | Calcium channel P-type blocker | 0.105 0.005 DBMET01193 0.069 0.03 DBMET01194 0.077 0.018 DBMET01195 0.069 0.03 DBMET01196 | DBMET01193 | |
| 0.084 | 0.017 | 0.121 | Opioid mu receptor agonist | 0.05 0.029 DBMET01193 0.121 0.009 DBMET01194 0.121 0.009 DBMET01196 | DBMET01196 | |
| 0.129 | 0.063 | 0.181 | Acetylcholine antagonist | 0.179 0.037 DBMET01193 0.122 0.069 DBMET01194 0.122 0.069 DBMET01196 0.181 0.036 DBMET01631 | DBMET01631 | |
| 0.071 | 0.006 | 0.148 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.05 0.011 DBMET01193 0.148 0.003 DBMET01194 0.029 0.026 DBMET01195 0.148 0.003 DBMET01196 | DBMET01196 | |
| 0.14 | 0.075 | 0.162 | Heat shock protein 70 antagonist | 0.133 0.106 DBMET01193 0.151 0.044 DBMET01194 0.157 0.032 DBMET01195 0.151 0.044 DBMET01196 0.162 0.025 DBMET01630 0.153 0.039 DBMET01631 | DBMET01630 | |
| 0.156 | 0.093 | 0.295 | Tumour necrosis factor antagonist | 0.172 0.074 DBMET01193 0.147 0.104 DBMET01194 0.295 0.019 DBMET01195 0.147 0.104 DBMET01196 0.158 0.091 DBMET01630 0.269 0.025 DBMET01631 | DBMET01195 | |
| 0.139 | 0.082 | 0.186 | Adenylate cyclase stimulant | 0.156 0.053 DBMET01193 0.157 0.052 DBMET01194 0.186 0.022 DBMET01195 0.157 0.052 DBMET01196 0.166 0.039 DBMET01630 0.179 0.027 DBMET01631 | DBMET01195 | |
| 0.246 | 0.19 | 0.379 | Alpha-glucosidase inhibitor | 0.379 0.124 DBMET01194 0.312 0.154 DBMET01195 0.379 0.124 DBMET01196 | DBMET01196 | |
| 0.125 | 0.069 | 0.272 | Cathepsin H inhibitor | 0.106 0.097 DBMET01193 0.178 0.03 DBMET01195 0.272 0.012 DBMET01630 0.138 0.056 DBMET01631 | DBMET01630 | |
| 0.14 | 0.086 | 0.176 | Cholinergic | 0.176 0.059 DBMET01631 | DBMET01631 | |
| 0.131 | 0.076 | 0.33 | Toll-Like receptor 9 antagonist | 0.121 0.085 DBMET01193 0.181 0.044 DBMET01195 0.33 0.009 DBMET01631 | DBMET01631 | |
| 0.172 | 0.119 | 0.267 | Potassium channel (Voltage-sensitive) blocker | 0.267 0.06 DBMET01193 0.205 0.092 DBMET01631 | DBMET01193 | |
| 0.08 | 0.027 | 0.135 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 DBMET01194 0.083 0.025 DBMET01195 0.064 0.045 DBMET01196 0.135 0.008 DBMET01630 0.096 0.017 DBMET01631 | DBMET01630 | |
| 0.081 | 0.03 | 0.13 | Alpha 1d adrenoreceptor antagonist | 0.13 0.017 DBMET01193 0.056 0.044 DBMET01194 0.056 0.044 DBMET01196 0.088 0.027 DBMET01631 | DBMET01193 | |
| 0.089 | 0.039 | 0.105 | CC chemokine 5 receptor agonist | 0.093 0.031 DBMET01193 0.098 0.024 DBMET01194 0.104 0.018 DBMET01195 0.098 0.024 DBMET01196 0.105 0.017 DBMET01631 | DBMET01631 | |
| 0.203 | 0.153 | 0.395 | Insulysin inhibitor | 0.228 0.119 DBMET01193 0.221 0.127 DBMET01194 0.395 0.023 DBMET01195 0.221 0.127 DBMET01196 0.288 0.066 DBMET01630 0.253 0.094 DBMET01631 | DBMET01195 | |
| 0.209 | 0.16 | 0.607 | Transcription factor NF kappa B inhibitor | 0.299 0.094 DBMET01194 0.315 0.087 DBMET01195 0.299 0.094 DBMET01196 0.607 0.03 DBMET01630 0.221 0.149 DBMET01631 | DBMET01630 | |
| 0.104 | 0.055 | 0.223 | Creatine kinase inhibitor | 0.131 0.034 DBMET01193 0.175 0.016 DBMET01194 0.223 0.008 DBMET01195 0.175 0.016 DBMET01196 0.112 0.047 DBMET01630 0.119 0.042 DBMET01631 | DBMET01195 | |
| 0.065 | 0.018 | 0.065 | CC chemokine 3 receptor antagonist | 0.061 0.019 DBMET01193 0.039 0.031 DBMET01631 | ||
| 0.074 | 0.029 | 0.126 | NMDA 2C receptor antagonist | 0.126 0.009 DBMET01193 0.093 0.018 DBMET01194 0.058 0.048 DBMET01195 0.093 0.018 DBMET01196 0.086 0.021 DBMET01631 | DBMET01193 | |
| 0.069 | 0.027 | 0.092 | Heme oxygenase stimulant | 0.073 0.021 DBMET01194 0.073 0.021 DBMET01196 0.092 0.009 DBMET01630 0.07 0.025 DBMET01631 | DBMET01630 | |
| 0.106 | 0.065 | 0.35 | Ferrochelatase inhibitor | 0.199 0.023 DBMET01193 0.35 0.005 DBMET01195 0.242 0.014 DBMET01630 0.192 0.024 DBMET01631 | DBMET01195 | |
| 0.053 | 0.013 | 0.082 | 5 Hydroxytryptamine 3B antagonist | 0.082 0.007 DBMET01193 0.08 0.007 DBMET01631 | DBMET01193 | |
| 0.236 | 0.197 | 0.353 | Transcription factor inhibitor | 0.225 0.205 DBMET01194 0.27 0.173 DBMET01195 0.225 0.205 DBMET01196 0.353 0.129 DBMET01630 | DBMET01630 | |
| 0.061 | 0.025 | 0.067 | Thromboxane synthase inhibitor | 0.058 0.03 DBMET01194 0.067 0.02 DBMET01195 0.058 0.03 DBMET01196 | DBMET01195 | |
| 0.049 | 0.014 | 0.067 | Kainate receptor agonist | 0.043 0.025 DBMET01193 0.045 0.02 DBMET01194 0.06 0.007 DBMET01195 0.045 0.02 DBMET01196 0.067 0.005 DBMET01630 0.056 0.009 DBMET01631 | DBMET01630 | |
| 0.231 | 0.196 | 0.415 | Antibacterial | 0.289 0.144 DBMET01194 0.243 0.183 DBMET01195 0.289 0.144 DBMET01196 0.415 0.07 DBMET01630 0.268 0.161 DBMET01631 | DBMET01630 | |
| 0.068 | 0.033 | 0.091 | Acetylcholine M3 receptor antagonist | 0.089 0.022 DBMET01193 0.084 0.024 DBMET01194 0.084 0.024 DBMET01196 0.091 0.021 DBMET01631 | DBMET01631 | |
| 0.076 | 0.042 | 0.124 | Phospholipase D inhibitor | 0.115 0.008 DBMET01193 0.124 0.005 DBMET01195 0.072 0.049 DBMET01630 0.12 0.006 DBMET01631 | DBMET01195 | |
| 0.061 | 0.028 | 0.069 | Leukotriene C antagonist | 0.064 0.021 DBMET01194 0.069 0.015 DBMET01195 0.064 0.021 DBMET01196 0.06 0.028 DBMET01630 | DBMET01195 | |
| 0.179 | 0.147 | 0.259 | Streptokinase A inhibitor | 0.259 0.097 DBMET01194 0.258 0.098 DBMET01195 0.259 0.097 DBMET01196 | DBMET01196 | |
| 0.111 | 0.079 | 0.158 | Transcription factor STAT6 inhibitor | 0.114 0.071 DBMET01193 0.118 0.063 DBMET01194 0.126 0.05 DBMET01195 0.118 0.063 DBMET01196 0.125 0.051 DBMET01630 0.158 0.018 DBMET01631 | DBMET01631 | |
| 0.055 | 0.023 | 0.079 | Oleamide hydrolase inhibitor | 0.046 0.031 DBMET01193 0.041 0.037 DBMET01194 0.079 0.013 DBMET01195 0.041 0.037 DBMET01196 | DBMET01195 | |
| 0.04 | 0.008 | 0.086 | LFA antagonist | 0.029 0.017 DBMET01194 0.029 0.017 DBMET01196 0.031 0.015 DBMET01630 0.086 0.004 DBMET01631 | DBMET01631 | |
| 0.034 | 0.009 | 0.034 | CYP24 inhibitor | 0.031 0.01 DBMET01194 0.031 0.01 DBMET01196 0.02 0.019 DBMET01630 | ||
| 0.077 | 0.053 | 0.156 | Nicotinic alpha4beta2 receptor antagonist | 0.128 0.014 DBMET01193 0.092 0.038 DBMET01195 0.093 0.038 DBMET01630 0.156 0.007 DBMET01631 | DBMET01631 | |
| 0.114 | 0.091 | 0.177 | Antibacterial (Helicobacter pylori) | 0.12 0.082 DBMET01193 0.11 0.098 DBMET01194 0.177 0.03 DBMET01195 0.11 0.098 DBMET01196 0.113 0.093 DBMET01631 | DBMET01195 | |
| 0.045 | 0.023 | 0.053 | Heme oxygenase inhibitor | 0.048 0.016 DBMET01193 0.053 0.01 DBMET01195 | DBMET01195 | |
| 0.098 | 0.078 | 0.233 | 5 Hydroxytryptamine 3A agonist | 0.233 0.008 DBMET01193 0.197 0.016 DBMET01195 0.197 0.016 DBMET01631 | DBMET01193 | |
| 0.052 | 0.031 | 0.068 | Squalene epoxidase inhibitor | 0.054 0.028 DBMET01194 0.065 0.016 DBMET01195 0.054 0.028 DBMET01196 0.068 0.015 DBMET01630 0.053 0.03 DBMET01631 | DBMET01630 | |
| 0.062 | 0.041 | 0.136 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.027 DBMET01193 0.136 0.013 DBMET01195 0.071 0.034 DBMET01630 0.07 0.035 DBMET01631 | DBMET01195 | |
| 0.069 | 0.05 | 0.261 | 5 Hydroxytryptamine 1F antagonist | 0.261 0.007 DBMET01193 0.181 0.012 DBMET01631 | DBMET01193 | |
| 0.061 | 0.043 | 0.141 | Adrenaline uptake inhibitor | 0.141 0.01 DBMET01193 0.134 0.012 DBMET01631 | DBMET01193 | |
| 0.097 | 0.08 | 0.243 | Cystathionine beta-synthase inhibitor | 0.179 0.03 DBMET01194 0.243 0.016 DBMET01195 0.179 0.03 DBMET01196 0.207 0.023 DBMET01630 0.106 0.07 DBMET01631 | DBMET01195 | |
| 0.061 | 0.044 | 0.242 | 5 Hydroxytryptamine 7 antagonist | 0.12 0.022 DBMET01193 0.242 0.009 DBMET01631 | DBMET01631 | |
| 0.038 | 0.022 | 0.059 | Nociceptin (N/OFQ) receptor antagonist | 0.059 0.01 DBMET01193 | DBMET01193 | |
| 0.045 | 0.029 | 0.071 | Dopamine D5 antagonist | 0.057 0.021 DBMET01194 0.057 0.021 DBMET01196 0.071 0.014 DBMET01631 | DBMET01631 | |
| 0.046 | 0.032 | 0.059 | Carbonic anhydrase VII inhibitor | 0.045 0.034 DBMET01193 0.059 0.02 DBMET01194 0.059 0.02 DBMET01196 | DBMET01196 | |
| 0.061 | 0.047 | 0.131 | 5 Hydroxytryptamine 3 agonist | 0.121 0.009 DBMET01193 0.077 0.029 DBMET01195 0.131 0.007 DBMET01631 | DBMET01631 | |
| 0.035 | 0.022 | 0.053 | Histone deacetylase 5 inhibitor | 0.053 0.015 DBMET01630 0.038 0.02 DBMET01631 | DBMET01630 | |
| 0.067 | 0.055 | 0.111 | Protein kinase C beta inhibitor | 0.111 0.01 DBMET01193 0.068 0.051 DBMET01194 0.103 0.012 DBMET01195 0.068 0.051 DBMET01196 0.107 0.011 DBMET01631 | DBMET01193 | |
| 0.039 | 0.027 | 0.062 | Histone deacetylase 9 inhibitor | 0.062 0.011 DBMET01195 0.06 0.012 DBMET01630 0.038 0.029 DBMET01631 | DBMET01195 | |
| 0.037 | 0.025 | 0.057 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.057 0.008 DBMET01195 0.035 0.028 DBMET01631 | DBMET01195 | |
| 0.065 | 0.054 | 0.105 | MDM2 inhibitor | 0.079 0.021 DBMET01193 0.105 0.005 DBMET01195 0.078 0.023 DBMET01631 | DBMET01195 | |
| 0.069 | 0.06 | 0.142 | Alpha 1 adrenoreceptor antagonist | 0.142 0.031 DBMET01193 0.108 0.041 DBMET01631 | DBMET01193 | |
| 0.023 | 0.015 | 0.039 | ICAM 1 antagonist | 0.022 0.02 DBMET01194 0.022 0.018 DBMET01195 0.022 0.02 DBMET01196 0.024 0.013 DBMET01630 0.039 0.004 DBMET01631 | DBMET01631 | |
| 0.041 | 0.033 | 0.056 | Opioid kappa receptor agonist | 0.056 0.02 DBMET01194 0.056 0.02 DBMET01196 | DBMET01196 | |
| 0.017 | 0.009 | 0.023 | NMDA receptor phencyclidine site antagonist | 0.023 0.006 DBMET01193 0.019 0.007 DBMET01194 0.019 0.007 DBMET01196 | DBMET01193 | |
| 0.092 | 0.084 | 0.124 | Toll-Like receptor 4 antagonist | 0.124 0.04 DBMET01194 0.124 0.04 DBMET01196 0.12 0.043 DBMET01630 0.115 0.049 DBMET01631 | DBMET01196 | |
| 0.014 | 0.007 | 0.035 | Integrin beta2 antagonist | 0.011 0.01 DBMET01630 0.035 0.004 DBMET01631 | DBMET01631 | |
| 0.038 | 0.031 | 0.088 | Dopamine D5 agonist | 0.088 0.005 DBMET01193 0.066 0.009 DBMET01194 0.087 0.005 DBMET01195 0.066 0.009 DBMET01196 0.039 0.029 DBMET01630 0.069 0.009 DBMET01631 | DBMET01193 | |
| 0.069 | 0.063 | 0.127 | GABA aminotransferase inhibitor | 0.086 0.039 DBMET01194 0.119 0.016 DBMET01195 0.086 0.039 DBMET01196 0.127 0.014 DBMET01630 0.078 0.049 DBMET01631 | DBMET01630 | |
| 0.051 | 0.047 | 0.091 | Aromatase inhibitor | 0.069 0.035 DBMET01194 0.087 0.025 DBMET01195 0.069 0.035 DBMET01196 0.091 0.023 DBMET01630 | DBMET01630 | |
| 0.12 | 0.116 | 0.199 | Thiol protease inhibitor | 0.142 0.077 DBMET01193 0.159 0.061 DBMET01195 0.199 0.039 DBMET01630 | DBMET01630 | |
| 0.048 | 0.044 | 0.09 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 DBMET01194 0.059 0.025 DBMET01195 0.058 0.026 DBMET01196 0.09 0.008 DBMET01630 0.049 0.041 DBMET01631 | DBMET01630 | |
| 0.049 | 0.046 | 0.083 | Nicotinic alpha3beta2 receptor antagonist | 0.069 0.019 DBMET01193 0.07 0.018 DBMET01195 0.083 0.012 DBMET01631 | DBMET01631 | |
| 0.033 | 0.03 | 0.079 | Histone deacetylase 7 inhibitor | 0.079 0.011 DBMET01195 0.074 0.012 DBMET01630 | DBMET01195 | |
| 0.134 | 0.132 | 0.354 | Psychostimulant | 0.194 0.083 DBMET01193 0.314 0.039 DBMET01195 0.354 0.031 DBMET01631 | DBMET01631 | |
| 0.039 | 0.037 | 0.058 | Nerve growth factor antagonist | 0.046 0.024 DBMET01193 0.058 0.011 DBMET01195 0.044 0.028 DBMET01631 | DBMET01195 | |
| 0.145 | 0.143 | 0.793 | Aldehyde oxidase inhibitor | 0.303 0.065 DBMET01193 0.304 0.065 DBMET01194 0.793 0.004 DBMET01195 0.304 0.065 DBMET01196 0.288 0.07 DBMET01630 0.232 0.089 DBMET01631 | DBMET01195 | |
| 0.017 | 0.016 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.014 DBMET01194 0.02 0.014 DBMET01196 | DBMET01196 | |
| 0.038 | 0.037 | 0.09 | Dopamine D2 agonist | 0.061 0.02 DBMET01194 0.061 0.02 DBMET01196 0.09 0.012 DBMET01631 | DBMET01631 | |
| 0.111 | 0.111 | 0.233 | Cytidine deaminase inhibitor | 0.168 0.063 DBMET01195 0.127 0.094 DBMET01630 0.233 0.034 DBMET01631 | DBMET01631 | |
| 0.013 | 0.014 | 0.031 | Dipeptidyl peptidase VIII inhibitor | 0.031 0.005 DBMET01193 | DBMET01193 | |
| 0.086 | 0.087 | 0.121 | Phosphodiesterase 6D inhibitor | 0.091 0.073 DBMET01194 0.121 0.024 DBMET01195 0.091 0.073 DBMET01196 0.09 0.076 DBMET01630 0.119 0.026 DBMET01631 | DBMET01195 | |
| 0.016 | 0.018 | 0.06 | 5-Alpha-reductase 2 inhibitor | 0.018 0.016 DBMET01193 0.06 0.007 DBMET01195 | DBMET01195 | |
| 0.11 | 0.113 | 0.156 | Papain-like protease (SARS coronavirus) inhibitor | 0.138 0.047 DBMET01194 0.138 0.047 DBMET01196 0.156 0.029 DBMET01630 0.121 0.079 DBMET01631 | DBMET01630 | |
| 0.01 | 0.015 | 0.016 | Integrin alphaLbeta2 antagonist | 0.016 0.006 DBMET01631 | DBMET01631 | |
| 0.024 | 0.029 | 0.036 | Histone deacetylase class IIa inhibitor | 0.036 0.019 DBMET01630 0.028 0.025 DBMET01631 | DBMET01630 | |
| 0.047 | 0.052 | 0.137 | 5 Hydroxytryptamine 3 antagonist | 0.137 0.011 DBMET01193 0.069 0.029 DBMET01631 | DBMET01193 | |
| 0.032 | 0.037 | 0.068 | Dopamine D3 agonist | 0.068 0.012 DBMET01631 | DBMET01631 | |
| 0.034 | 0.04 | 0.081 | Histamine H3 receptor antagonist | 0.081 0.016 DBMET01193 | DBMET01193 | |
| 0.046 | 0.052 | 0.095 | Dipeptidyl peptidase inhibitor | 0.095 0.01 DBMET01193 | DBMET01193 | |
| 0.049 | 0.055 | 0.173 | Biliverdin reductase inhibitor | 0.074 0.029 DBMET01193 0.173 0.007 DBMET01195 0.108 0.016 DBMET01630 0.074 0.029 DBMET01631 | DBMET01195 | |
| 0.036 | 0.043 | 0.102 | 5 Hydroxytryptamine 1A agonist | 0.05 0.029 DBMET01193 0.102 0.015 DBMET01631 | DBMET01631 | |
| 0.076 | 0.084 | 0.191 | NADH dehydrogenase inhibitor | 0.112 0.034 DBMET01193 0.191 0.011 DBMET01195 0.112 0.034 DBMET01630 0.093 0.052 DBMET01631 | DBMET01195 | |
| 0.094 | 0.102 | 0.206 | Microtubule formation inhibitor | 0.206 0.018 DBMET01195 0.165 0.03 DBMET01630 0.109 0.075 DBMET01631 | DBMET01195 | |
| 0.025 | 0.033 | 0.041 | Estrogen-related receptor gamma antagonist | 0.041 0.005 DBMET01193 0.034 0.01 DBMET01194 0.038 0.006 DBMET01195 0.034 0.01 DBMET01196 0.033 0.01 DBMET01631 | DBMET01193 | |
| 0.121 | 0.13 | 0.245 | Interferon gamma antagonist | 0.144 0.087 DBMET01194 0.245 0.029 DBMET01195 0.144 0.087 DBMET01196 0.188 0.046 DBMET01630 0.132 0.108 DBMET01631 | DBMET01195 | |
| 0.069 | 0.078 | 0.133 | Viral attachment inhibitor | 0.133 0.011 DBMET01193 | DBMET01193 | |
| 0.031 | 0.042 | 0.042 | Glutamate (mGluR8) antagonist | 0.042 0.014 DBMET01193 | DBMET01193 | |
| 0.031 | 0.042 | 0.036 | Adenosine uptake inhibitor | 0.036 0.021 DBMET01195 | DBMET01195 | |
| 0.082 | 0.094 | 0.195 | GABA C receptor rho-1 antagonist | 0.176 0.013 DBMET01193 0.195 0.009 DBMET01195 0.125 0.036 DBMET01630 0.143 0.025 DBMET01631 | DBMET01195 | |
| 0.086 | 0.099 | 0.203 | Adenylate cyclase inhibitor | 0.111 0.075 DBMET01194 0.203 0.025 DBMET01195 0.111 0.075 DBMET01196 0.161 0.038 DBMET01631 | DBMET01195 | |
| 0.03 | 0.043 | 0.101 | Estradiol 17 beta-dehydrogenase inhibitor | 0.082 0.013 DBMET01194 0.101 0.01 DBMET01195 0.082 0.013 DBMET01196 | DBMET01195 | |
| 0.052 | 0.065 | 0.129 | 5 Hydroxytryptamine 5A antagonist | 0.063 0.04 DBMET01193 0.058 0.048 DBMET01195 0.129 0.01 DBMET01631 | DBMET01631 | |
| 0.022 | 0.035 | 0.027 | Thrombin receptor antagonist | 0.027 0.022 DBMET01630 0.026 0.023 DBMET01631 | DBMET01630 | |
| 0.017 | 0.031 | 0.025 | Sigma 2 receptor antagonist | 0.025 0.02 DBMET01631 | DBMET01631 | |
| 0.083 | 0.097 | 0.186 | 5 Hydroxytryptamine antagonist | 0.186 0.037 DBMET01193 0.15 0.049 DBMET01631 | DBMET01193 | |
| 0.035 | 0.049 | 0.068 | Glycine transporter inhibitor | 0.068 0.021 DBMET01193 0.043 0.038 DBMET01195 | DBMET01193 | |
| 0.096 | 0.11 | 0.2 | Estrogen antagonist | 0.2 0.013 DBMET01194 0.191 0.014 DBMET01195 0.2 0.013 DBMET01196 0.105 0.085 DBMET01631 | DBMET01196 | |
| 0.085 | 0.1 | 0.323 | Adenylate kinase inhibitor | 0.111 0.052 DBMET01193 0.323 0.006 DBMET01195 0.236 0.011 DBMET01630 0.1 0.066 DBMET01631 | DBMET01195 | |
| 0.107 | 0.123 | 0.142 | Vanilloid 1 agonist | 0.122 0.084 DBMET01194 0.141 0.048 DBMET01195 0.122 0.084 DBMET01196 0.142 0.047 DBMET01630 0.123 0.081 DBMET01631 | DBMET01630 | |
| 0.147 | 0.163 | 0.205 | Tumour necrosis factor alpha release inhibitor | 0.157 0.149 DBMET01194 0.205 0.104 DBMET01195 0.157 0.149 DBMET01196 | DBMET01195 | |
| 0.155 | 0.17 | 0.568 | Hypoglycemic | 0.237 0.085 DBMET01194 0.222 0.095 DBMET01195 0.237 0.085 DBMET01196 0.568 0.01 DBMET01630 0.169 0.149 DBMET01631 | DBMET01630 | |
| 0.009 | 0.025 | 0.06 | 5-Alpha-reductase 1 inhibitor | 0.06 0.006 DBMET01195 | DBMET01195 | |
| 0.015 | 0.032 | 0.034 | Sigma 1 receptor antagonist | 0.034 0.015 DBMET01631 | DBMET01631 | |
| 0.108 | 0.125 | 0.309 | Mannose-6-phosphate isomerase inhibitor | 0.145 0.069 DBMET01193 0.309 0.005 DBMET01195 0.23 0.017 DBMET01630 | DBMET01195 | |
| 0.033 | 0.05 | 0.04 | Integrin alpha1beta1 antagonist | 0.04 0.022 DBMET01630 0.039 0.024 DBMET01631 | DBMET01630 | |
| 0.037 | 0.054 | 0.083 | Carbonic anhydrase XIV inhibitor | 0.05 0.032 DBMET01194 0.083 0.016 DBMET01195 0.05 0.032 DBMET01196 | DBMET01195 | |
| 0.181 | 0.199 | 0.194 | Beta lactamase inhibitor | 0.194 0.189 DBMET01195 | DBMET01195 | |
| 0.025 | 0.044 | 0.091 | 5-Alpha-reductase inhibitor | 0.091 0.011 DBMET01195 | DBMET01195 | |
| 0.04 | 0.059 | 0.065 | Dopamine beta hydroxylase inhibitor | 0.062 0.013 DBMET01193 0.047 0.038 DBMET01194 0.065 0.011 DBMET01195 0.047 0.038 DBMET01196 0.049 0.033 DBMET01630 0.063 0.013 DBMET01631 | DBMET01195 | |
| 0.116 | 0.135 | 0.26 | GABA C receptor rho-2 antagonist | 0.179 0.043 DBMET01193 0.26 0.01 DBMET01195 0.181 0.042 DBMET01630 0.172 0.049 DBMET01631 | DBMET01195 | |
| 0.037 | 0.057 | 0.065 | Dipeptidyl peptidase IV inhibitor | 0.065 0.011 DBMET01193 | DBMET01193 | |
| 0.054 | 0.074 | 0.232 | Catalase inhibitor | 0.221 0.012 DBMET01195 0.232 0.01 DBMET01630 0.066 0.059 DBMET01631 | DBMET01630 | |
| 0.171 | 0.192 | 0.326 | Gastrin inhibitor | 0.211 0.133 DBMET01193 0.326 0.018 DBMET01195 0.198 0.152 DBMET01630 0.231 0.103 DBMET01631 | DBMET01195 | |
| 0.042 | 0.064 | 0.065 | Factor III inhibitor | 0.051 0.032 DBMET01194 0.051 0.032 DBMET01196 0.065 0.013 DBMET01630 | DBMET01630 | |
| 0.064 | 0.085 | 0.101 | Vanilloid 4 agonist | 0.083 0.036 DBMET01193 0.101 0.016 DBMET01195 0.071 0.06 DBMET01630 | DBMET01195 | |
| 0.021 | 0.043 | 0.064 | Kainate receptor 2 antagonist | 0.041 0.021 DBMET01630 0.064 0.01 DBMET01631 | DBMET01631 | |
| 0.118 | 0.14 | 0.463 | Melanin inhibitor | 0.161 0.068 DBMET01194 0.181 0.051 DBMET01195 0.161 0.068 DBMET01196 0.463 0.008 DBMET01630 0.135 0.105 DBMET01631 | DBMET01630 | |
| 0.072 | 0.094 | 0.274 | Triose-phosphate isomerase inhibitor | 0.104 0.044 DBMET01193 0.274 0.005 DBMET01195 0.258 0.006 DBMET01630 0.08 0.077 DBMET01631 | DBMET01195 | |
| 0.015 | 0.037 | 0.051 | Methionyl aminopeptidase 2 inhibitor | 0.051 0.006 DBMET01631 | DBMET01631 | |
| 0.048 | 0.07 | 0.108 | Alpha 1a adrenoreceptor antagonist | 0.108 0.033 DBMET01193 0.084 0.043 DBMET01631 | DBMET01193 | |
| 0.009 | 0.033 | 0.019 | Dipeptidyl peptidase IX inhibitor | 0.019 0.009 DBMET01193 | DBMET01193 | |
| 0.058 | 0.082 | 0.146 | Exportin-1 inhibitor | 0.065 0.056 DBMET01193 0.146 0.004 DBMET01195 0.107 0.006 DBMET01630 0.077 0.03 DBMET01631 | DBMET01195 | |
| 0.061 | 0.086 | 0.124 | Macrophage migration inhibitory factor inhibitor | 0.124 0.024 DBMET01194 0.083 0.048 DBMET01195 0.124 0.024 DBMET01196 | DBMET01196 | |
| 0.013 | 0.038 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.014 DBMET01195 | DBMET01195 | |
| 0.024 | 0.049 | 0.048 | Dipeptidyl peptidase II inhibitor | 0.048 0.01 DBMET01193 0.031 0.025 DBMET01195 | DBMET01193 | |
| 0.045 | 0.071 | 0.093 | 5 Hydroxytryptamine 1A antagonist | 0.082 0.039 DBMET01193 0.093 0.034 DBMET01631 | DBMET01631 | |
| 0.039 | 0.065 | 0.165 | Aconitate hydratase inhibitor | 0.048 0.042 DBMET01193 0.165 0.004 DBMET01195 0.097 0.009 DBMET01630 | DBMET01195 | |
| 0.019 | 0.046 | 0.037 | Histone deacetylase 11 inhibitor | 0.037 0.019 DBMET01630 0.027 0.026 DBMET01631 | DBMET01630 | |
| 0.019 | 0.046 | 0.037 | Histone deacetylase class IV inhibitor | 0.037 0.019 DBMET01630 0.027 0.026 DBMET01631 | DBMET01630 | |
| 0.049 | 0.076 | 0.177 | Phenylalanine 4-hydroxylase inhibitor | 0.087 0.033 DBMET01193 0.082 0.036 DBMET01194 0.177 0.009 DBMET01195 0.082 0.036 DBMET01196 0.104 0.024 DBMET01630 0.067 0.05 DBMET01631 | DBMET01195 | |
| 0.038 | 0.066 | 0.052 | Bombesin 2 receptor antagonist | 0.045 0.042 DBMET01193 0.049 0.035 DBMET01195 0.052 0.031 DBMET01631 | DBMET01631 | |
| 0.086 | 0.113 | 0.35 | Amylase inhibitor | 0.17 0.055 DBMET01194 0.347 0.013 DBMET01195 0.17 0.055 DBMET01196 0.35 0.013 DBMET01630 0.134 0.072 DBMET01631 | DBMET01630 | |
| 0.037 | 0.065 | 0.134 | Acyl-CoA dehydrogenase inhibitor | 0.05 0.043 DBMET01193 0.134 0.011 DBMET01195 0.077 0.023 DBMET01630 | DBMET01195 | |
| 0.039 | 0.067 | 0.171 | Protein kinase C eta inhibitor | 0.093 0.019 DBMET01193 0.051 0.042 DBMET01194 0.171 0.005 DBMET01195 0.051 0.042 DBMET01196 0.082 0.023 DBMET01631 | DBMET01195 | |
| 0.045 | 0.073 | 0.121 | 5 Hydroxytryptamine 5 antagonist | 0.056 0.044 DBMET01193 0.053 0.05 DBMET01195 0.121 0.011 DBMET01631 | DBMET01631 | |
| 0.087 | 0.116 | 0.535 | TRPA1 agonist | 0.101 0.085 DBMET01194 0.15 0.031 DBMET01195 0.101 0.085 DBMET01196 0.535 0.003 DBMET01630 0.115 0.065 DBMET01631 | DBMET01630 | |
| 0.048 | 0.078 | 0.107 | NMDA 2 receptor antagonist | 0.093 0.036 DBMET01194 0.062 0.06 DBMET01195 0.093 0.036 DBMET01196 0.107 0.028 DBMET01631 | DBMET01631 | |
| 0.047 | 0.077 | 0.126 | Neuronal nicotinic receptor antagonist | 0.126 0.016 DBMET01193 0.061 0.054 DBMET01195 0.093 0.028 DBMET01631 | DBMET01193 | |
| 0.049 | 0.079 | 0.074 | Histone deacetylase inhibitor | 0.061 0.051 DBMET01195 0.074 0.036 DBMET01631 | DBMET01631 | |
| 0.038 | 0.068 | 0.097 | Histamine agonist | 0.097 0.009 DBMET01193 0.065 0.023 DBMET01631 | DBMET01193 | |
| 0.108 | 0.138 | 0.164 | Heat shock protein 90 antagonist | 0.137 0.088 DBMET01193 0.163 0.062 DBMET01194 0.164 0.06 DBMET01195 0.163 0.062 DBMET01196 | DBMET01195 | |
| 0.025 | 0.056 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 DBMET01193 0.036 0.023 DBMET01195 0.036 0.023 DBMET01631 | DBMET01193 | |
| 0.082 | 0.113 | 0.212 | GABA C receptor antagonist | 0.189 0.015 DBMET01193 0.212 0.011 DBMET01195 0.132 0.042 DBMET01630 0.148 0.031 DBMET01631 | DBMET01195 | |
| 0.02 | 0.051 | 0.031 | Complement factor 1s inhibitor | 0.031 0.007 DBMET01195 0.027 0.012 DBMET01630 0.025 0.018 DBMET01631 | DBMET01195 | |
| 0.015 | 0.046 | 0.037 | Retinoid X beta receptor antagonist | 0.037 0.003 DBMET01195 0.026 0.006 DBMET01630 | DBMET01195 | |
| 0.12 | 0.151 | 0.271 | Anesthetic general | 0.149 0.114 DBMET01193 0.137 0.129 DBMET01194 0.271 0.041 DBMET01195 0.137 0.129 DBMET01196 0.187 0.082 DBMET01630 0.191 0.08 DBMET01631 | DBMET01195 | |
| 0.04 | 0.073 | 0.069 | CC chemokine 2 receptor antagonist | 0.069 0.026 DBMET01631 | DBMET01631 | |
| 0.036 | 0.068 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.091 0.006 DBMET01195 0.1 0.005 DBMET01630 | DBMET01630 | |
| 0.044 | 0.076 | 0.072 | 5 Hydroxytryptamine 7 agonist | 0.069 0.02 DBMET01193 0.058 0.034 DBMET01195 0.072 0.018 DBMET01631 | DBMET01631 | |
| 0.055 | 0.089 | 0.157 | Glutamate dehydrogenase inhibitor | 0.076 0.049 DBMET01193 0.157 0.015 DBMET01195 0.104 0.029 DBMET01630 | DBMET01195 | |
| 0.008 | 0.043 | 0.015 | CXC chemokine 4 receptor agonist | 0.015 0.01 DBMET01193 0.014 0.013 DBMET01195 0.015 0.011 DBMET01631 | DBMET01631 | |
| 0.007 | 0.042 | 0.035 | Kainate receptor 1 antagonist | 0.035 0.009 DBMET01631 | DBMET01631 | |
| 0.014 | 0.05 | 0.021 | Factor XIII inhibitor | 0.021 0.013 DBMET01193 0.021 0.013 DBMET01195 0.02 0.016 DBMET01631 | DBMET01195 | |
| 0.072 | 0.107 | 0.309 | UDP-glucose 4-epimerase inhibitor | 0.126 0.039 DBMET01193 0.309 0.01 DBMET01195 0.291 0.011 DBMET01630 0.095 0.067 DBMET01631 | DBMET01195 | |
| 0.087 | 0.123 | 0.309 | Aldehyde dehydrogenase inhibitor | 0.123 0.068 DBMET01194 0.239 0.02 DBMET01195 0.123 0.068 DBMET01196 0.309 0.011 DBMET01630 0.114 0.077 DBMET01631 | DBMET01630 | |
| 0.052 | 0.088 | 0.13 | Aminopeptidase I inhibitor | 0.086 0.037 DBMET01193 0.13 0.017 DBMET01195 0.079 0.043 DBMET01630 | DBMET01195 | |
| 0.026 | 0.063 | 0.043 | Delayed rectifier potassium channel blocker | 0.043 0.017 DBMET01195 | DBMET01195 | |
| 0.033 | 0.069 | 0.064 | Glutamate (mGluR4) antagonist | 0.064 0.012 DBMET01193 0.054 0.017 DBMET01195 | DBMET01193 | |
| 0.037 | 0.074 | 0.066 | Acetylcholine M2 receptor antagonist | 0.066 0.04 DBMET01193 0.057 0.048 DBMET01631 | DBMET01193 | |
| 0.019 | 0.058 | 0.068 | Fumarate hydratase inhibitor | 0.068 0.009 DBMET01195 0.041 0.018 DBMET01630 | DBMET01195 | |
| 0.012 | 0.051 | 0.043 | Imidazoline I1 receptor antagonist | 0.043 0.004 DBMET01193 0.028 0.008 DBMET01195 0.041 0.004 DBMET01631 | DBMET01193 | |
| 0.032 | 0.072 | 0.058 | Histamine H1 receptor agonist | 0.056 0.012 DBMET01193 0.058 0.01 DBMET01195 0.048 0.022 DBMET01631 | DBMET01195 | |
| 0.069 | 0.108 | 0.267 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.105 0.049 DBMET01193 0.267 0.008 DBMET01195 0.137 0.031 DBMET01630 0.083 0.075 DBMET01631 | DBMET01195 | |
| 0.02 | 0.061 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET01195 0.026 0.02 DBMET01631 | DBMET01195 | |
| 0.065 | 0.106 | 0.272 | HIV-1 integrase (Overall Integration) inhibitor | 0.097 0.057 DBMET01193 0.272 0.004 DBMET01195 0.115 0.043 DBMET01630 0.119 0.04 DBMET01631 | DBMET01195 | |
| 0.037 | 0.078 | 0.062 | CC chemokine receptor 2B antagonist | 0.062 0.017 DBMET01193 | DBMET01193 | |
| 0.037 | 0.08 | 0.068 | Alpha-mannosidase inhibitor | 0.065 0.021 DBMET01193 0.068 0.018 DBMET01195 0.067 0.019 DBMET01630 0.052 0.039 DBMET01631 | DBMET01195 | |
| 0.059 | 0.102 | 0.126 | NMDA receptor antagonist | 0.095 0.05 DBMET01194 0.095 0.05 DBMET01196 0.126 0.033 DBMET01631 | DBMET01631 | |
| 0.109 | 0.153 | 0.157 | Neuropeptide Y1 antagonist | 0.129 0.103 DBMET01195 0.157 0.054 DBMET01631 | DBMET01631 | |
| 0.037 | 0.08 | 0.103 | Alpha 1 adrenoreceptor agonist | 0.103 0.016 DBMET01193 0.053 0.046 DBMET01195 0.074 0.026 DBMET01631 | DBMET01193 | |
| 0.129 | 0.173 | 0.268 | Neurotrophic factor enhancer | 0.151 0.137 DBMET01193 0.182 0.096 DBMET01194 0.268 0.029 DBMET01195 0.182 0.096 DBMET01196 0.164 0.118 DBMET01630 0.166 0.115 DBMET01631 | DBMET01195 | |
| 0.044 | 0.088 | 0.095 | 5 Hydroxytryptamine 1 antagonist | 0.084 0.044 DBMET01193 0.095 0.039 DBMET01631 | DBMET01631 | |
| 0.049 | 0.093 | 0.17 | Glutamate decarboxylase inhibitor | 0.073 0.052 DBMET01193 0.07 0.054 DBMET01194 0.17 0.01 DBMET01195 0.07 0.054 DBMET01196 0.167 0.01 DBMET01630 | DBMET01195 | |
| 0.053 | 0.097 | 0.06 | Prolactin release inhibitor | 0.06 0.054 DBMET01631 | DBMET01631 | |
| 0.057 | 0.102 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.074 0.051 DBMET01193 0.105 0.01 DBMET01195 0.088 0.025 DBMET01630 0.071 0.057 DBMET01631 | DBMET01195 | |
| 0.062 | 0.109 | 0.123 | Histamine H2 receptor antagonist | 0.123 0.019 DBMET01195 0.103 0.032 DBMET01631 | DBMET01195 | |
| 0.054 | 0.102 | 0.219 | Glycine receptor agonist | 0.074 0.047 DBMET01193 0.219 0.004 DBMET01195 0.079 0.039 DBMET01630 | DBMET01195 | |
| 0.054 | 0.102 | 0.139 | Acetylcholine nicotinic antagonist | 0.139 0.024 DBMET01193 0.072 0.065 DBMET01195 0.105 0.036 DBMET01631 | DBMET01193 | |
| 0.152 | 0.2 | 0.328 | DNA synthesis inhibitor | 0.227 0.086 DBMET01193 0.248 0.068 DBMET01195 0.328 0.035 DBMET01630 0.247 0.069 DBMET01631 | DBMET01630 | |
| 0.087 | 0.136 | 0.177 | Sodium channel blocker | 0.177 0.042 DBMET01193 | DBMET01193 | |
| 0.119 | 0.169 | 0.307 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.096 DBMET01193 0.307 0.01 DBMET01195 0.275 0.018 DBMET01630 0.168 0.077 DBMET01631 | DBMET01195 | |
| 0.038 | 0.087 | 0.078 | Sphingosine kinase 2 inhibitor | 0.062 0.03 DBMET01193 0.078 0.016 DBMET01195 0.059 0.033 DBMET01631 | DBMET01195 | |
| 0.01 | 0.059 | 0.027 | Urotensin II antagonist | 0.027 0.012 DBMET01193 | DBMET01193 | |
| 0.021 | 0.071 | 0.059 | Histone deacetylase 8 inhibitor | 0.059 0.017 DBMET01195 | DBMET01195 | |
| 0.11 | 0.161 | 0.281 | Pyruvate kinase inhibitor | 0.177 0.096 DBMET01194 0.281 0.053 DBMET01195 0.177 0.096 DBMET01196 0.261 0.058 DBMET01630 | DBMET01195 | |
| 0.028 | 0.079 | 0.043 | Thymidine kinase inhibitor | 0.043 0.025 DBMET01195 0.039 0.031 DBMET01631 | DBMET01195 | |
| 0.035 | 0.087 | 0.066 | Leukotriene B4 antagonist | 0.066 0.022 DBMET01195 | DBMET01195 | |
| 0.033 | 0.087 | 0.076 | Prolyl endopeptidase inhibitor | 0.076 0.012 DBMET01195 0.062 0.022 DBMET01630 | DBMET01195 | |
| 0.027 | 0.081 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 DBMET01193 0.044 0.03 DBMET01195 0.049 0.025 DBMET01631 | DBMET01631 | |
| 0.064 | 0.118 | 0.179 | Breast cancer-resistant protein inhibitor | 0.086 0.071 DBMET01194 0.179 0.017 DBMET01195 0.086 0.071 DBMET01196 0.126 0.035 DBMET01630 0.123 0.037 DBMET01631 | DBMET01195 | |
| 0.025 | 0.079 | 0.049 | Protein kinase C beta I inhibitor | 0.04 0.009 DBMET01193 0.049 0.004 DBMET01195 | DBMET01195 | |
| 0.018 | 0.073 | 0.026 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET01193 0.026 0.019 DBMET01195 0.026 0.017 DBMET01631 | DBMET01631 | |
| 0.021 | 0.076 | 0.034 | Factor XIIIa inhibitor | 0.034 0.03 DBMET01631 | DBMET01631 | |
| 0.108 | 0.164 | 0.245 | DNA methyltransferase I inhibitor | 0.134 0.124 DBMET01194 0.234 0.054 DBMET01195 0.134 0.124 DBMET01196 0.17 0.087 DBMET01630 0.245 0.049 DBMET01631 | DBMET01631 | |
| 0.016 | 0.073 | 0.05 | Acid ceramidase inhibitor | 0.03 0.009 DBMET01193 0.05 0.003 DBMET01195 0.028 0.013 DBMET01631 | DBMET01195 | |
| 0.157 | 0.213 | 0.545 | Cholesterol antagonist | 0.21 0.156 DBMET01194 0.545 0.026 DBMET01195 0.21 0.156 DBMET01196 0.305 0.088 DBMET01630 0.197 0.167 DBMET01631 | DBMET01195 | |
| 0.083 | 0.14 | 0.214 | Toll-Like receptor 2 antagonist | 0.109 0.091 DBMET01193 0.125 0.073 DBMET01194 0.214 0.018 DBMET01195 0.125 0.073 DBMET01196 0.147 0.054 DBMET01630 0.128 0.07 DBMET01631 | DBMET01195 | |
| 0.005 | 0.061 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET01195 | DBMET01195 | |
| 0.048 | 0.105 | 0.091 | CC chemokine receptor antagonist | 0.091 0.041 DBMET01195 | DBMET01195 | |
| 0.024 | 0.081 | 0.067 | Guanylate cyclase inhibitor | 0.067 0.006 DBMET01195 0.04 0.033 DBMET01630 | DBMET01195 | |
| 0.012 | 0.07 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.01 DBMET01195 0.02 0.01 DBMET01630 | DBMET01630 | |
| 0.046 | 0.104 | 0.131 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.081 0.05 DBMET01194 0.11 0.033 DBMET01195 0.081 0.05 DBMET01196 0.131 0.025 DBMET01630 0.066 0.065 DBMET01631 | DBMET01630 | |
| 0.063 | 0.121 | 0.097 | MAP kinase kinase 7 inhibitor | 0.097 0.015 DBMET01193 0.08 0.045 DBMET01194 0.094 0.019 DBMET01195 0.08 0.045 DBMET01196 0.073 0.071 DBMET01630 0.089 0.026 DBMET01631 | DBMET01193 | |
| 0.029 | 0.087 | 0.046 | Leukotriene C4 antagonist | 0.046 0.014 DBMET01195 0.039 0.026 DBMET01630 | DBMET01195 | |
| 0.09 | 0.149 | 0.524 | Interleukin 1 antagonist | 0.524 0.005 DBMET01195 0.267 0.015 DBMET01630 0.246 0.019 DBMET01631 | DBMET01195 | |
| 0.058 | 0.117 | 0.122 | Estrogen receptor alpha antagonist | 0.088 0.038 DBMET01194 0.122 0.018 DBMET01195 0.088 0.038 DBMET01196 0.073 0.061 DBMET01631 | DBMET01195 | |
| 0.039 | 0.098 | 0.074 | Leukotriene antagonist | 0.074 0.037 DBMET01195 | DBMET01195 | |
| 0.004 | 0.064 | 0.031 | Imidazoline I2 receptor antagonist | 0.013 0.005 DBMET01193 0.031 0.003 DBMET01195 0.011 0.007 DBMET01631 | DBMET01195 | |
| 0.015 | 0.074 | 0.032 | NMDA 2D receptor antagonist | 0.032 0.014 DBMET01631 | DBMET01631 | |
| 0.002 | 0.062 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET01195 | DBMET01195 | |
| 0.143 | 0.203 | 0.201 | ErbB-1 antagonist | 0.161 0.151 DBMET01194 0.161 0.151 DBMET01196 0.201 0.088 DBMET01631 | DBMET01631 | |
| 0.023 | 0.083 | 0.041 | Membrane dipeptidase inhibitor | 0.041 0.025 DBMET01195 0.041 0.024 DBMET01630 | DBMET01630 | |
| 0.025 | 0.086 | 0.061 | Mannosidase inhibitor | 0.061 0.016 DBMET01193 0.059 0.018 DBMET01195 0.055 0.02 DBMET01630 0.045 0.032 DBMET01631 | DBMET01193 | |
| 0.042 | 0.104 | 0.074 | Pregnane X receptor antagonist | 0.074 0.01 DBMET01195 0.07 0.014 DBMET01630 | DBMET01195 | |
| 0.049 | 0.111 | 0.077 | Transcription factor RelA inhibitor | 0.076 0.021 DBMET01195 0.077 0.021 DBMET01630 | DBMET01630 | |
| 0.019 | 0.081 | 0.046 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.046 0.011 DBMET01195 | DBMET01195 | |
| 0.013 | 0.074 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 DBMET01195 | DBMET01195 | |
| 0.04 | 0.103 | 0.123 | Purinergic P2X1 antagonist | 0.123 0.011 DBMET01195 0.095 0.018 DBMET01630 | DBMET01195 | |
| 0.004 | 0.069 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DBMET01195 | DBMET01195 | |
| 0.012 | 0.077 | 0.022 | Neuraminidase (Influenza B) inhibitor | 0.022 0.013 DBMET01195 | DBMET01195 | |
| 0.041 | 0.107 | 0.284 | Porphobilinogen synthase inhibitor | 0.074 0.052 DBMET01193 0.284 0.006 DBMET01195 0.161 0.018 DBMET01630 | DBMET01195 | |
| 0.009 | 0.077 | 0.031 | 5 Hydroxytryptamine 1D agonist | 0.031 0.018 DBMET01631 | DBMET01631 | |
| 0.051 | 0.121 | 0.157 | Histamine N-methyltransferase inhibitor | 0.11 0.037 DBMET01193 0.157 0.012 DBMET01195 0.108 0.039 DBMET01631 | DBMET01195 | |
| 0.008 | 0.078 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.012 DBMET01195 | DBMET01195 | |
| 0.025 | 0.095 | 0.058 | Dopamine D4 antagonist | 0.058 0.043 DBMET01631 | DBMET01631 | |
| 0.014 | 0.085 | 0.041 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.024 DBMET01193 0.031 0.024 DBMET01195 0.041 0.011 DBMET01631 | DBMET01631 | |
| 0.015 | 0.086 | 0.054 | Kainate receptor antagonist | 0.054 0.019 DBMET01631 | DBMET01631 | |
| 0.102 | 0.174 | 0.608 | Nitric oxide antagonist | 0.16 0.088 DBMET01194 0.16 0.088 DBMET01196 0.608 0.009 DBMET01630 | DBMET01630 | |
| 0.144 | 0.216 | 0.313 | RNA-directed DNA polymerase inhibitor | 0.183 0.127 DBMET01193 0.313 0.029 DBMET01195 0.193 0.11 DBMET01630 0.187 0.12 DBMET01631 | DBMET01195 | |
| 0.079 | 0.151 | 0.165 | Sodium channel (voltage-gated) blocker | 0.165 0.045 DBMET01193 0.114 0.091 DBMET01195 | DBMET01193 | |
| 0.047 | 0.12 | 0.066 | Histone deacetylase SIRT3 inhibitor | 0.063 0.041 DBMET01193 0.064 0.038 DBMET01195 0.066 0.035 DBMET01631 | DBMET01631 | |
| 0.173 | 0.246 | 0.299 | DNA polymerase beta inhibitor | 0.299 0.166 DBMET01195 | DBMET01195 | |
| 0.045 | 0.118 | 0.074 | Ryanodine receptor antagonist | 0.068 0.021 DBMET01193 0.074 0.013 DBMET01195 0.066 0.024 DBMET01631 | DBMET01195 | |
| 0.015 | 0.089 | 0.069 | Retinoid X alpha receptor agonist | 0.069 0.009 DBMET01195 0.041 0.019 DBMET01630 | DBMET01195 | |
| 0.023 | 0.096 | 0.064 | Retinoid X receptor antagonist | 0.064 0.005 DBMET01195 0.046 0.016 DBMET01630 | DBMET01195 | |
| 0.007 | 0.081 | 0.033 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.033 0.016 DBMET01195 0.03 0.018 DBMET01630 | DBMET01195 | |
| 0.021 | 0.095 | 0.055 | Retinoid X alpha receptor antagonist | 0.055 0.004 DBMET01195 0.04 0.015 DBMET01630 | DBMET01195 | |
| 0.01 | 0.085 | 0.041 | Nicotinic alpha4beta2 receptor agonist | 0.04 0.008 DBMET01193 0.041 0.007 DBMET01195 0.033 0.013 DBMET01631 | DBMET01195 | |
| 0.047 | 0.122 | 0.177 | Ornithine decarboxylase inhibitor | 0.155 0.01 DBMET01195 0.177 0.006 DBMET01630 | DBMET01630 | |
| 0.008 | 0.083 | 0.019 | Telomerase stimulant | 0.019 0.009 DBMET01195 | DBMET01195 | |
| 0.012 | 0.087 | 0.063 | Retinoid X receptor agonist | 0.063 0.013 DBMET01195 0.05 0.018 DBMET01630 | DBMET01195 | |
| 0.052 | 0.127 | 0.117 | Keratolytic | 0.071 0.062 DBMET01194 0.117 0.023 DBMET01195 0.071 0.062 DBMET01196 0.117 0.023 DBMET01630 | DBMET01630 | |
| 0.005 | 0.082 | 0.019 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.019 0.004 DBMET01195 | DBMET01195 | |
| 0.015 | 0.092 | 0.03 | Lysophosphatidic acid 2 receptor antagonist | 0.03 0.022 DBMET01195 | DBMET01195 | |
| 0.066 | 0.143 | 0.187 | Electrolyte absorption antagonist | 0.092 0.071 DBMET01193 0.187 0.01 DBMET01195 0.111 0.045 DBMET01630 0.093 0.069 DBMET01631 | DBMET01195 | |
| 0.024 | 0.101 | 0.06 | Glutamate (mGluR8) agonist | 0.06 0.007 DBMET01195 0.041 0.021 DBMET01630 | DBMET01195 | |
| 0.011 | 0.089 | 0.076 | Sirtuin 2 inhibitor | 0.076 0.006 DBMET01195 | DBMET01195 | |
| 0.013 | 0.091 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.029 0.012 DBMET01195 | DBMET01195 | |
| 0.028 | 0.106 | 0.061 | Farnesyltransferase inhibitor | 0.061 0.02 DBMET01195 0.048 0.03 DBMET01630 | DBMET01195 | |
| 0.036 | 0.115 | 0.143 | Alpha adrenoreceptor agonist | 0.143 0.018 DBMET01193 0.134 0.019 DBMET01631 | DBMET01193 | |
| 0.021 | 0.099 | 0.056 | Thromboxane A2 antagonist | 0.056 0.031 DBMET01195 | DBMET01195 | |
| 0.012 | 0.091 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.017 DBMET01630 | DBMET01630 | |
| 0.009 | 0.089 | 0.032 | Histone deacetylase 10 inhibitor | 0.032 0.019 DBMET01630 | DBMET01630 | |
| 0.007 | 0.088 | 0.016 | Cyclin D2 inhibitor | 0.016 0.005 DBMET01193 0.016 0.005 DBMET01195 | DBMET01195 | |
| 0.039 | 0.119 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.107 0.025 DBMET01195 0.119 0.017 DBMET01630 0.067 0.063 DBMET01631 | DBMET01630 | |
| 0.006 | 0.087 | 0.017 | Thromboxane A2 agonist | 0.017 0.008 DBMET01195 0.016 0.01 DBMET01630 | DBMET01195 | |
| 0.056 | 0.137 | 0.134 | Sphingomyelinase inhibitor | 0.134 0.032 DBMET01195 0.086 0.078 DBMET01630 | DBMET01195 | |
| 0.034 | 0.115 | 0.12 | 5 Hydroxytryptamine 1B antagonist | 0.057 0.056 DBMET01193 0.12 0.017 DBMET01631 | DBMET01631 | |
| 0.033 | 0.115 | 0.097 | 5 Hydroxytryptamine 3A antagonist | 0.087 0.025 DBMET01193 0.097 0.018 DBMET01631 | DBMET01631 | |
| 0.057 | 0.14 | 0.156 | Falcipain 3 inhibitor | 0.099 0.071 DBMET01193 0.144 0.039 DBMET01195 0.156 0.034 DBMET01630 | DBMET01630 | |
| 0.031 | 0.114 | 0.178 | Phosphofructokinase-1 inhibitor | 0.164 0.015 DBMET01195 0.178 0.014 DBMET01630 | DBMET01630 | |
| 0.066 | 0.149 | 0.15 | Proteasome inhibitor | 0.126 0.06 DBMET01195 0.15 0.047 DBMET01630 | DBMET01630 | |
| 0.072 | 0.157 | 0.252 | DOPA decarboxylase inhibitor | 0.098 0.081 DBMET01193 0.103 0.071 DBMET01194 0.252 0.004 DBMET01195 0.103 0.071 DBMET01196 0.122 0.043 DBMET01630 | DBMET01195 | |
| 0.03 | 0.116 | 0.114 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 DBMET01193 0.114 0.012 DBMET01195 0.114 0.012 DBMET01630 | DBMET01630 | |
| 0.068 | 0.154 | 0.2 | Glutamate release inhibitor | 0.084 0.076 DBMET01193 0.2 0.005 DBMET01195 0.084 0.077 DBMET01630 | DBMET01195 | |
| 0.02 | 0.106 | 0.083 | Ornithine carbamoyltransferase inhibitor | 0.074 0.024 DBMET01195 0.083 0.021 DBMET01630 | DBMET01630 | |
| 0.004 | 0.091 | 0.033 | Human herpes virus 5 capsid protein P40 inhibitor | 0.033 0.003 DBMET01195 | DBMET01195 | |
| 0.015 | 0.102 | 0.032 | 5 Hydroxytryptamine 6 agonist | 0.032 0.014 DBMET01193 0.027 0.025 DBMET01631 | DBMET01193 | |
| 0.103 | 0.191 | 0.202 | Pregnane X receptor agonist | 0.202 0.01 DBMET01195 0.141 0.071 DBMET01630 0.131 0.097 DBMET01631 | DBMET01195 | |
| 0.102 | 0.189 | 0.241 | DNA methylase inhibitor | 0.241 0.053 DBMET01195 0.163 0.107 DBMET01630 0.233 0.059 DBMET01631 | DBMET01195 | |
| 0.01 | 0.098 | 0.026 | Lysine carboxypeptidase inhibitor | 0.026 0.02 DBMET01195 | DBMET01195 | |
| 0.003 | 0.091 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 DBMET01195 | DBMET01195 | |
| 0.011 | 0.099 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.045 0.007 DBMET01193 0.043 0.008 DBMET01195 | DBMET01193 | |
| 0.111 | 0.2 | 0.236 | Immunostimulant | 0.189 0.127 DBMET01195 0.236 0.102 DBMET01630 | DBMET01630 | |
| 0.019 | 0.107 | 0.081 | 5 Hydroxytryptamine 1 agonist | 0.081 0.025 DBMET01631 | DBMET01631 | |
| 0.009 | 0.098 | 0.02 | Estrogen-related receptor gamma agonist | 0.02 0.011 DBMET01195 | DBMET01195 | |
| 0.036 | 0.126 | 0.064 | Sphingosine kinase inhibitor | 0.057 0.045 DBMET01193 0.064 0.032 DBMET01195 0.055 0.049 DBMET01630 0.059 0.041 DBMET01631 | DBMET01195 | |
| 0.06 | 0.15 | 0.097 | mTOR complex 2 inhibitor | 0.097 0.037 DBMET01195 | DBMET01195 | |
| 0.053 | 0.144 | 0.199 | Protein kinase C delta inhibitor | 0.172 0.014 DBMET01195 0.199 0.009 DBMET01631 | DBMET01631 | |
| 0.066 | 0.156 | 0.168 | Carbonic anhydrase XV inhibitor | 0.168 0.025 DBMET01195 0.119 0.047 DBMET01630 | DBMET01195 | |
| 0.063 | 0.154 | 0.124 | Estrogen-related receptor beta agonist | 0.084 0.055 DBMET01193 0.082 0.06 DBMET01194 0.124 0.009 DBMET01195 0.082 0.06 DBMET01196 0.086 0.051 DBMET01630 | DBMET01195 | |
| 0.061 | 0.152 | 0.141 | Anabolic | 0.141 0.023 DBMET01195 0.118 0.041 DBMET01630 | DBMET01195 | |
| 0.013 | 0.104 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 DBMET01195 | DBMET01195 | |
| 0.006 | 0.097 | 0.024 | Nicotinic alpha4 receptor agonist | 0.024 0.005 DBMET01193 0.016 0.011 DBMET01195 0.016 0.013 DBMET01631 | DBMET01193 | |
| 0.007 | 0.1 | 0.032 | Arginase inhibitor | 0.032 0.029 DBMET01195 | DBMET01195 | |
| 0.022 | 0.115 | 0.056 | Thromboxane antagonist | 0.056 0.035 DBMET01195 | DBMET01195 | |
| 0.026 | 0.119 | 0.104 | NMDA receptor glycine site agonist | 0.104 0.014 DBMET01195 0.083 0.026 DBMET01630 | DBMET01195 | |
| 0.047 | 0.14 | 0.104 | Glutamate (mGluR6) antagonist | 0.064 0.053 DBMET01193 0.104 0.009 DBMET01195 0.069 0.042 DBMET01630 | DBMET01195 | |
| 0.028 | 0.121 | 0.052 | Glutamate (mGluR group III) antagonist | 0.047 0.024 DBMET01193 0.052 0.019 DBMET01195 | DBMET01195 | |
| 0.046 | 0.139 | 0.078 | Adenosine A3 receptor antagonist | 0.078 0.045 DBMET01195 | DBMET01195 | |
| 0.016 | 0.11 | 0.072 | Alpha 1d adrenoreceptor agonist | 0.072 0.007 DBMET01193 0.069 0.008 DBMET01195 0.048 0.018 DBMET01631 | DBMET01193 | |
| 0.007 | 0.1 | 0.019 | Histamine H4 receptor agonist | 0.019 0.013 DBMET01193 | DBMET01193 | |
| 0.002 | 0.096 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 DBMET01195 | DBMET01195 | |
| 0.044 | 0.138 | 0.132 | Acetylcholine nicotinic agonist | 0.097 0.04 DBMET01193 0.079 0.058 DBMET01195 0.132 0.023 DBMET01631 | DBMET01631 | |
| 0.006 | 0.1 | 0.022 | Alpha 2a adrenoreceptor agonist | 0.022 0.008 DBMET01193 0.02 0.009 DBMET01195 | DBMET01193 | |
| 0.199 | 0.295 | 0.246 | MAP kinase 1 inhibitor | 0.246 0.238 DBMET01195 | DBMET01195 | |
| 0.033 | 0.128 | 0.059 | Epithelial sodium channel blocker | 0.059 0.029 DBMET01195 0.058 0.032 DBMET01631 | DBMET01195 | |
| 0.028 | 0.123 | 0.105 | Acetylcholine M5 receptor agonist | 0.093 0.024 DBMET01193 0.105 0.017 DBMET01195 0.071 0.043 DBMET01631 | DBMET01195 | |
| 0.089 | 0.185 | 0.147 | DNA repair enzyme inhibitor | 0.13 0.055 DBMET01193 0.147 0.034 DBMET01195 0.112 0.091 DBMET01631 | DBMET01195 | |
| 0.109 | 0.205 | 0.325 | Platelet antagonist | 0.325 0.045 DBMET01630 0.162 0.133 DBMET01631 | DBMET01630 | |
| 0.048 | 0.144 | 0.201 | Carbonic anhydrase VI inhibitor | 0.201 0.013 DBMET01195 0.112 0.033 DBMET01630 | DBMET01195 | |
| 0.004 | 0.101 | 0.038 | 3C-Like protease (MERS coronavirus) inhibitor | 0.038 0.002 DBMET01630 | DBMET01630 | |
| 0.011 | 0.108 | 0.036 | Nicotinic acid receptor 2 antagonist | 0.036 0.007 DBMET01195 0.033 0.009 DBMET01630 | DBMET01195 | |
| 0.016 | 0.113 | 0.051 | Oxytocin agonist | 0.051 0.023 DBMET01195 | DBMET01195 | |
| 0.078 | 0.176 | 0.497 | Peroxidase inhibitor | 0.199 0.059 DBMET01193 0.153 0.076 DBMET01194 0.497 0.01 DBMET01195 0.153 0.076 DBMET01196 0.192 0.061 DBMET01630 0.111 0.11 DBMET01631 | DBMET01195 | |
| 0.024 | 0.122 | 0.271 | Alcohol oxidase inhibitor | 0.048 0.047 DBMET01193 0.271 0.005 DBMET01195 0.255 0.005 DBMET01630 | DBMET01195 | |
| 0.01 | 0.108 | 0.023 | Prostaglandin F2 alpha agonist | 0.023 0.014 DBMET01195 | DBMET01195 | |
| 0.014 | 0.112 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.031 0.021 DBMET01193 0.034 0.017 DBMET01195 | DBMET01195 | |
| 0.06 | 0.158 | 0.173 | Thioredoxin reductase inhibitor | 0.173 0.006 DBMET01630 | DBMET01630 | |
| 0.042 | 0.141 | 0.067 | Beta 3 adrenoreceptor antagonist | 0.067 0.039 DBMET01195 0.06 0.055 DBMET01631 | DBMET01195 | |
| 0.047 | 0.146 | 0.173 | Aminopeptidase B inhibitor | 0.095 0.068 DBMET01193 0.173 0.029 DBMET01195 0.15 0.038 DBMET01630 | DBMET01195 | |
| 0.009 | 0.109 | 0.025 | Protease (Human cytomegalovirus) inhibitor | 0.025 0.012 DBMET01195 | DBMET01195 | |
| 0.006 | 0.107 | 0.017 | Complement factor D inhibitor | 0.017 0.016 DBMET01195 | DBMET01195 | |
| 0.12 | 0.22 | 0.29 | Cyclic AMP phosphodiesterase inhibitor | 0.166 0.128 DBMET01193 0.29 0.046 DBMET01195 0.29 0.046 DBMET01631 | DBMET01631 | |
| 0.035 | 0.136 | 0.095 | NMDA receptor agonist | 0.095 0.021 DBMET01195 0.072 0.034 DBMET01630 | DBMET01195 | |
| 0.023 | 0.123 | 0.094 | Cannabinoid CB1 receptor agonist | 0.094 0.022 DBMET01195 | DBMET01195 | |
| 0.022 | 0.123 | 0.042 | Sphingosine kinase 1 inhibitor | 0.038 0.035 DBMET01193 0.042 0.027 DBMET01195 | DBMET01195 | |
| 0.033 | 0.135 | 0.167 | Histidine decarboxylase inhibitor | 0.167 0.017 DBMET01195 0.086 0.039 DBMET01630 | DBMET01195 | |
| 0.024 | 0.126 | 0.142 | Argininosuccinate synthase inhibitor | 0.056 0.04 DBMET01193 0.142 0.012 DBMET01195 0.136 0.013 DBMET01630 | DBMET01195 | |
| 0.202 | 0.304 | 0.52 | 5 Hydroxytryptamine release inhibitor | 0.348 0.117 DBMET01193 0.52 0.026 DBMET01195 0.303 0.161 DBMET01630 0.274 0.196 DBMET01631 | DBMET01195 | |
| 0.029 | 0.132 | 0.062 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.062 0.037 DBMET01195 0.058 0.042 DBMET01630 | DBMET01195 | |
| 0.003 | 0.106 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.009 DBMET01630 | DBMET01630 | |
| 0.115 | 0.218 | 0.185 | Neurotensin receptor agonist | 0.14 0.128 DBMET01193 0.139 0.131 DBMET01194 0.185 0.045 DBMET01195 0.139 0.131 DBMET01196 0.151 0.098 DBMET01630 0.142 0.122 DBMET01631 | DBMET01195 | |
| 0.012 | 0.115 | 0.03 | Histone deacetylase 2 inhibitor | 0.03 0.028 DBMET01631 | DBMET01631 | |
| 0.028 | 0.131 | 0.067 | Lysine-specific demethylase 1A inhibitor | 0.067 0.02 DBMET01195 0.067 0.02 DBMET01631 | DBMET01631 | |
| 0.09 | 0.193 | 0.234 | NOS3 expression enhancer | 0.157 0.066 DBMET01194 0.157 0.066 DBMET01196 0.234 0.03 DBMET01630 0.126 0.105 DBMET01631 | DBMET01630 | |
| 0.04 | 0.144 | 0.066 | Interferon inducer | 0.066 0.041 DBMET01193 0.066 0.042 DBMET01195 0.065 0.042 DBMET01631 | DBMET01195 | |
| 0.016 | 0.12 | 0.069 | NMDA 2A receptor antagonist | 0.069 0.024 DBMET01195 0.056 0.032 DBMET01631 | DBMET01195 | |
| 0.062 | 0.167 | 0.148 | Beta glucuronidase inhibitor | 0.093 0.082 DBMET01194 0.115 0.051 DBMET01195 0.093 0.082 DBMET01196 0.148 0.026 DBMET01630 0.132 0.036 DBMET01631 | DBMET01630 | |
| 0.028 | 0.134 | 0.063 | Histamine H4 receptor antagonist | 0.063 0.017 DBMET01193 0.055 0.023 DBMET01631 | DBMET01193 | |
| 0.102 | 0.209 | 0.353 | Non-steroidal antiinflammatory agent | 0.353 0.019 DBMET01195 0.195 0.075 DBMET01630 | DBMET01195 | |
| 0.016 | 0.124 | 0.076 | Carbonic anhydrase VB inhibitor | 0.076 0.024 DBMET01195 0.07 0.028 DBMET01630 | DBMET01195 | |
| 0.078 | 0.186 | 0.145 | Protein kinase stimulant | 0.143 0.073 DBMET01195 0.145 0.072 DBMET01630 | DBMET01630 | |
| 0.022 | 0.131 | 0.063 | 5 Hydroxytryptamine 2B agonist | 0.063 0.008 DBMET01193 0.041 0.024 DBMET01195 0.049 0.014 DBMET01631 | DBMET01193 | |
| 0.013 | 0.122 | 0.035 | Histone deacetylase class I inhibitor | 0.035 0.033 DBMET01195 | DBMET01195 | |
| 0.022 | 0.132 | 0.096 | Potassium channel Kv1.1 blocker | 0.096 0.004 DBMET01195 0.037 0.029 DBMET01630 | DBMET01195 | |
| 0.044 | 0.154 | 0.113 | Glycine receptor antagonist | 0.099 0.033 DBMET01193 0.113 0.022 DBMET01195 0.087 0.046 DBMET01630 0.087 0.046 DBMET01631 | DBMET01195 | |
| 0.026 | 0.137 | 0.098 | 5 Hydroxytryptamine 2A agonist | 0.094 0.017 DBMET01193 0.059 0.048 DBMET01195 0.098 0.015 DBMET01631 | DBMET01631 | |
| 0.024 | 0.136 | 0.074 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.074 0.004 DBMET01195 0.044 0.024 DBMET01630 | DBMET01195 | |
| 0.017 | 0.13 | 0.068 | Potassium channel Kv1.3 blocker | 0.068 0.016 DBMET01195 0.048 0.032 DBMET01630 | DBMET01195 | |
| 0.013 | 0.127 | 0.035 | Purinergic P2Y15 antagonist | 0.035 0.01 DBMET01195 | DBMET01195 | |
| 0.084 | 0.198 | 0.244 | Arachidonic acid antagonist | 0.244 0.007 DBMET01195 0.181 0.052 DBMET01630 | DBMET01195 | |
| 0.008 | 0.123 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET01193 0.019 0.011 DBMET01195 | DBMET01193 | |
| 0.057 | 0.172 | 0.144 | Carbonic anhydrase III inhibitor | 0.085 0.083 DBMET01194 0.144 0.031 DBMET01195 0.085 0.083 DBMET01196 0.121 0.043 DBMET01630 | DBMET01195 | |
| 0.004 | 0.12 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 DBMET01195 | DBMET01195 | |
| 0.004 | 0.12 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 DBMET01195 | DBMET01195 | |
| 0.009 | 0.125 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET01195 | DBMET01195 | |
| 0.012 | 0.128 | 0.037 | CDK4/cyclin D3 inhibitor | 0.037 0.011 DBMET01195 0.026 0.024 DBMET01631 | DBMET01195 | |
| 0.022 | 0.139 | 0.048 | 5 Hydroxytryptamine 4 antagonist | 0.048 0.042 DBMET01631 | DBMET01631 | |
| 0.029 | 0.147 | 0.067 | Heparanase inhibitor | 0.062 0.02 DBMET01195 0.067 0.014 DBMET01630 | DBMET01630 | |
| 0.009 | 0.127 | 0.023 | Isoleucine-tRNA ligase inhibitor | 0.023 0.015 DBMET01195 | DBMET01195 | |
| 0.039 | 0.157 | 0.117 | Glutamate (mGluR7) antagonist | 0.117 0.005 DBMET01195 0.074 0.036 DBMET01630 | DBMET01195 | |
| 0.008 | 0.127 | 0.053 | Glutamate (mGluR1a) agonist | 0.053 0.005 DBMET01195 | DBMET01195 | |
| 0.048 | 0.169 | 0.078 | Cell adhesion molecule inhibitor | 0.078 0.056 DBMET01631 | DBMET01631 | |
| 0.029 | 0.15 | 0.082 | Carbonic anhydrase VA inhibitor | 0.081 0.036 DBMET01195 0.082 0.035 DBMET01630 | DBMET01630 | |
| 0.013 | 0.135 | 0.033 | ATP citrate lysase inhibitor | 0.033 0.02 DBMET01195 | DBMET01195 | |
| 0.071 | 0.193 | 0.231 | Toll-Like receptor antagonist | 0.117 0.09 DBMET01195 0.231 0.021 DBMET01631 | DBMET01631 | |
| 0.05 | 0.172 | 0.123 | Glutathione S-transferase inhibitor | 0.123 0.021 DBMET01195 0.099 0.038 DBMET01630 | DBMET01195 | |
| 0.043 | 0.168 | 0.076 | Phosphodiesterase VI inhibitor | 0.076 0.049 DBMET01195 0.071 0.06 DBMET01631 | DBMET01195 | |
| 0.048 | 0.174 | 0.146 | Expectorant | 0.146 0.037 DBMET01195 0.089 0.083 DBMET01630 | DBMET01195 | |
| 0.023 | 0.15 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | 0.067 0.023 DBMET01193 0.063 0.026 DBMET01195 0.059 0.03 DBMET01631 | DBMET01193 | |
| 0.148 | 0.275 | 0.283 | DNA directed DNA polymerase inhibitor | 0.283 0.171 DBMET01195 | DBMET01195 | |
| 0.011 | 0.139 | 0.028 | Myristoyl transferase inhibitor | 0.028 0.018 DBMET01193 0.026 0.021 DBMET01195 0.028 0.017 DBMET01631 | DBMET01631 | |
| 0.056 | 0.184 | 0.145 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.054 DBMET01193 0.145 0.006 DBMET01195 0.105 0.029 DBMET01630 | DBMET01195 | |
| 0.013 | 0.142 | 0.067 | Peroxisome proliferator-activated receptor alpha agonist | 0.067 0.023 DBMET01195 | DBMET01195 | |
| 0.01 | 0.14 | 0.047 | Diamine oxidase inhibitor | 0.047 0.017 DBMET01195 | DBMET01195 | |
| 0.058 | 0.188 | 0.171 | Mucolytic | 0.171 0.022 DBMET01195 0.095 0.086 DBMET01630 | DBMET01195 | |
| 0.01 | 0.141 | 0.029 | Potassium channel small-conductance Ca-activated activator | 0.029 0.025 DBMET01195 | DBMET01195 | |
| 0.04 | 0.172 | 0.08 | Interferon agonist | 0.077 0.057 DBMET01193 0.08 0.052 DBMET01195 0.077 0.057 DBMET01631 | DBMET01195 | |
| 0.022 | 0.154 | 0.091 | 5 Hydroxytryptamine 1D antagonist | 0.091 0.026 DBMET01631 | DBMET01631 | |
| 0.007 | 0.139 | 0.052 | Uridine phosphorylase inhibitor | 0.052 0.007 DBMET01195 | DBMET01195 | |
| 0.004 | 0.138 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 DBMET01195 | DBMET01195 | |
| 0.035 | 0.169 | 0.075 | Aryl hydrocarbon receptor antagonist | 0.074 0.033 DBMET01195 0.075 0.031 DBMET01630 | DBMET01630 | |
| 0.094 | 0.229 | 0.182 | CF transmembrane conductance regulator agonist | 0.132 0.113 DBMET01193 0.182 0.034 DBMET01195 0.13 0.118 DBMET01630 | DBMET01195 | |
| 0.014 | 0.149 | 0.055 | Protein kinase C beta II inhibitor | 0.04 0.011 DBMET01193 0.055 0.005 DBMET01195 0.031 0.026 DBMET01631 | DBMET01195 | |
| 0.018 | 0.153 | 0.053 | NMDA receptor subunit 3B antagonist | 0.053 0.023 DBMET01195 | DBMET01195 | |
| 0.021 | 0.157 | 0.083 | Protein kinase C theta inhibitor | 0.083 0.013 DBMET01631 | DBMET01631 | |
| 0.013 | 0.15 | 0.071 | Geranyltranstransferase inhibitor | 0.071 0.007 DBMET01195 0.05 0.023 DBMET01630 | DBMET01195 | |
| 0.024 | 0.16 | 0.076 | Carbonic anhydrase V inhibitor | 0.076 0.038 DBMET01195 0.076 0.038 DBMET01630 | DBMET01630 | |
| 0.029 | 0.167 | 0.18 | Carbonic anhydrase XIII inhibitor | 0.09 0.043 DBMET01195 0.18 0.017 DBMET01630 | DBMET01630 | |
| 0.035 | 0.173 | 0.081 | Metalloproteinase-2 inhibitor | 0.069 0.067 DBMET01195 0.081 0.052 DBMET01630 | DBMET01630 | |
| 0.037 | 0.175 | 0.157 | Monophenol monooxygenase inhibitor | 0.094 0.08 DBMET01194 0.157 0.044 DBMET01195 0.094 0.08 DBMET01196 0.135 0.053 DBMET01630 | DBMET01195 | |
| 0.028 | 0.167 | 0.103 | MAO B inhibitor | 0.103 0.058 DBMET01195 0.087 0.069 DBMET01630 0.092 0.064 DBMET01631 | DBMET01195 | |
| 0.026 | 0.166 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | 0.089 0.031 DBMET01195 0.066 0.048 DBMET01630 | DBMET01195 | |
| 0.011 | 0.152 | 0.027 | MAP3K8 inhibitor | 0.027 0.025 DBMET01195 | DBMET01195 | |
| 0.032 | 0.173 | 0.098 | Potassium channel intermediate-conductance Ca-activated blocker | 0.098 0.009 DBMET01195 | DBMET01195 | |
| 0.02 | 0.161 | 0.072 | Potassium channel (Inward rectifier) blocker | 0.072 0.016 DBMET01195 | DBMET01195 | |
| 0.024 | 0.166 | 0.1 | Alpha 2 adrenoreceptor agonist | 0.096 0.016 DBMET01193 0.1 0.015 DBMET01631 | DBMET01631 | |
| 0.011 | 0.154 | 0.046 | Cholesterol ester transfer protein antagonist | 0.046 0.009 DBMET01195 | DBMET01195 | |
| 0.084 | 0.229 | 0.149 | Potassium channel blocker | 0.149 0.136 DBMET01193 | DBMET01193 | |
| 0.011 | 0.156 | 0.067 | Carbonic anhydrase I inhibitor | 0.067 0.03 DBMET01195 | DBMET01195 | |
| 0.022 | 0.167 | 0.078 | Cyclin-dependent kinase 6 inhibitor | 0.078 0.023 DBMET01193 0.063 0.038 DBMET01631 | DBMET01193 | |
| 0.012 | 0.158 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.011 DBMET01195 | DBMET01195 | |
| 0.05 | 0.197 | 0.605 | Tubulin antagonist | 0.605 0.005 DBMET01195 | DBMET01195 | |
| 0.061 | 0.208 | 0.136 | Glutamate (mGluR7) agonist | 0.095 0.07 DBMET01193 0.136 0.018 DBMET01195 | DBMET01195 | |
| 0.01 | 0.158 | 0.034 | Carnitine palmitoyltransferase 1 inhibitor | 0.034 0.024 DBMET01193 | DBMET01193 | |
| 0.019 | 0.167 | 0.062 | Nicotinic neuronal receptor agonist | 0.062 0.034 DBMET01193 0.062 0.034 DBMET01631 | DBMET01631 | |
| 0.011 | 0.159 | 0.051 | Peptide deformylase inhibitor | 0.051 0.009 DBMET01195 | DBMET01195 | |
| 0.063 | 0.211 | 0.27 | NADPH oxidase inhibitor | 0.27 0.017 DBMET01193 0.253 0.02 DBMET01195 | DBMET01193 | |
| 0.01 | 0.158 | 0.057 | Catechol O-methyltransferase inhibitor | 0.057 0.007 DBMET01195 | DBMET01195 | |
| 0.019 | 0.168 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.064 0.019 DBMET01195 | DBMET01195 | |
| 0.055 | 0.205 | 0.125 | D-Ala-D-Ala ligase inhibitor | 0.125 0.012 DBMET01195 0.082 0.061 DBMET01630 | DBMET01195 | |
| 0.016 | 0.166 | 0.057 | Glutamate (mGluR5) agonist | 0.057 0.02 DBMET01195 | DBMET01195 | |
| 0.022 | 0.172 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.036 DBMET01195 | DBMET01195 | |
| 0.015 | 0.166 | 0.048 | Adenosine deaminase inhibitor | 0.048 0.032 DBMET01195 | DBMET01195 | |
| 0.01 | 0.161 | 0.036 | Retinoid X gamma receptor antagonist | 0.036 0.006 DBMET01195 | DBMET01195 | |
| 0.016 | 0.167 | 0.032 | Hedgehog signaling activator | 0.032 0.009 DBMET01195 | DBMET01195 | |
| 0.024 | 0.176 | 0.051 | Cytokine production stimulant | 0.051 0.027 DBMET01195 | DBMET01195 | |
| 0.011 | 0.163 | 0.05 | NMDA receptor subunit 3A antagonist | 0.05 0.02 DBMET01195 | DBMET01195 | |
| 0.038 | 0.19 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.054 0.042 DBMET01193 0.07 0.011 DBMET01195 | DBMET01195 | |
| 0.131 | 0.284 | 0.29 | Nitric-oxide synthase stimulant | 0.217 0.064 DBMET01193 0.29 0.014 DBMET01195 0.199 0.091 DBMET01630 | DBMET01195 | |
| 0.052 | 0.205 | 0.145 | Alkylator | 0.101 0.088 DBMET01195 0.145 0.049 DBMET01630 | DBMET01630 | |
| 0.002 | 0.155 | 0.009 | Progesterone receptor A antagonist | 0.009 0.008 DBMET01195 | DBMET01195 | |
| 0.04 | 0.194 | 0.134 | MAO inhibitor | 0.128 0.07 DBMET01195 0.106 0.085 DBMET01630 0.134 0.067 DBMET01631 | DBMET01631 | |
| 0.033 | 0.187 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | 0.073 0.024 DBMET01193 0.076 0.021 DBMET01195 | DBMET01195 | |
| 0.012 | 0.166 | 0.101 | Cannabinoid CB2 receptor antagonist | 0.101 0.014 DBMET01195 | DBMET01195 | |
| 0.009 | 0.164 | 0.036 | Phosphoglycerate kinase inhibitor | 0.036 0.023 DBMET01195 | DBMET01195 | |
| 0.024 | 0.179 | 0.185 | HIV-1 integrase (3'-Processing) inhibitor | 0.058 0.049 DBMET01194 0.058 0.049 DBMET01196 0.185 0.011 DBMET01630 | DBMET01630 | |
| 0.009 | 0.164 | 0.033 | Carnitine palmitoyltransferase inhibitor | 0.033 0.026 DBMET01193 | DBMET01193 | |
| 0.005 | 0.161 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.012 DBMET01193 0.017 0.015 DBMET01195 | DBMET01193 | |
| 0.016 | 0.173 | 0.059 | Histamine H2 receptor agonist | 0.041 0.033 DBMET01193 0.059 0.015 DBMET01195 | DBMET01195 | |
| 0.029 | 0.186 | 0.114 | Dihydroorotate oxidase inhibitor | 0.114 0.004 DBMET01195 0.062 0.025 DBMET01630 | DBMET01195 | |
| 0.031 | 0.188 | 0.115 | Androgen antagonist | 0.115 0.036 DBMET01195 | DBMET01195 | |
| 0.052 | 0.21 | 0.44 | Cyclooxygenase 1 inhibitor | 0.44 0.005 DBMET01195 | DBMET01195 | |
| 0.052 | 0.21 | 0.123 | MAP kinase kinase 1 inhibitor | 0.123 0.032 DBMET01195 0.093 0.066 DBMET01631 | DBMET01195 | |
| 0.036 | 0.195 | 0.115 | Myeloperoxidase inhibitor | 0.115 0.022 DBMET01195 0.083 0.061 DBMET01631 | DBMET01195 | |
| 0.015 | 0.18 | 0.037 | Retinoic acid alpha receptor agonist | 0.036 0.034 DBMET01195 0.037 0.032 DBMET01630 | DBMET01630 | |
| 0.026 | 0.191 | 0.059 | Botulinum neurotoxin type A inhibitor | 0.055 0.045 DBMET01195 0.059 0.039 DBMET01630 | DBMET01630 | |
| 0.063 | 0.229 | 0.175 | Protein-tyrosine phosphatase inhibitor | 0.124 0.108 DBMET01194 0.152 0.076 DBMET01195 0.124 0.108 DBMET01196 0.175 0.059 DBMET01630 | DBMET01630 | |
| 0.023 | 0.195 | 0.065 | Carbonic anhydrase stimulant | 0.064 0.036 DBMET01193 0.065 0.036 DBMET01195 | DBMET01195 | |
| 0.029 | 0.201 | 0.118 | MAO A inhibitor | 0.118 0.053 DBMET01195 0.095 0.068 DBMET01631 | DBMET01195 | |
| 0.009 | 0.182 | 0.034 | Trypsin II inhibitor | 0.034 0.017 DBMET01630 | DBMET01630 | |
| 0.088 | 0.263 | 0.168 | Sphingosine 1-phosphate receptor 5 antagonist | 0.168 0.036 DBMET01195 | DBMET01195 | |
| 0.009 | 0.183 | 0.074 | Carbonic anhydrase II inhibitor | 0.074 0.028 DBMET01195 | DBMET01195 | |
| 0.049 | 0.224 | 0.11 | AMP-activated protein kinase stimulant | 0.11 0.058 DBMET01195 | DBMET01195 | |
| 0.017 | 0.193 | 0.035 | Protein kinase (CK2) beta inhibitor | 0.032 0.027 DBMET01193 0.035 0.019 DBMET01195 | DBMET01195 | |
| 0.027 | 0.203 | 0.188 | CYP2A6 inhibitor | 0.188 0.009 DBMET01195 0.097 0.037 DBMET01630 | DBMET01195 | |
| 0.007 | 0.184 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | 0.039 0.018 DBMET01195 | DBMET01195 | |
| 0.008 | 0.185 | 0.023 | Retinoic acid receptor agonist | 0.023 0.017 DBMET01630 | DBMET01630 | |
| 0.028 | 0.206 | 0.124 | CD45 antagonist | 0.124 0.007 DBMET01195 | DBMET01195 | |
| 0.033 | 0.212 | 0.12 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.063 DBMET01195 | DBMET01195 | |
| 0.035 | 0.215 | 0.136 | Inducible nitric-oxide synthase inhibitor | 0.136 0.019 DBMET01195 0.09 0.047 DBMET01631 | DBMET01195 | |
| 0.057 | 0.241 | 0.238 | Photosensitizer | 0.238 0.007 DBMET01195 0.12 0.058 DBMET01630 | DBMET01195 | |
| 0.018 | 0.204 | 0.336 | TRPA1 antagonist | 0.336 0.004 DBMET01630 | DBMET01630 | |
| 0.02 | 0.208 | 0.047 | Vanilloid 3 antagonist | 0.047 0.01 DBMET01195 | DBMET01195 | |
| 0.007 | 0.196 | 0.063 | Farnesoid X receptor agonist | 0.063 0.009 DBMET01630 | DBMET01630 | |
| 0.016 | 0.205 | 0.06 | 5 Hydroxytryptamine 6 antagonist | 0.06 0.036 DBMET01193 0.055 0.041 DBMET01631 | DBMET01193 | |
| 0.002 | 0.192 | 0.013 | Carbonic anhydrase XI inhibitor | 0.013 0.009 DBMET01195 | DBMET01195 | |
| 0.021 | 0.211 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.043 DBMET01195 | DBMET01195 | |
| 0.055 | 0.247 | 0.166 | Cyclooxygenase 3 inhibitor | 0.103 0.099 DBMET01193 0.166 0.036 DBMET01195 | DBMET01195 | |
| 0.017 | 0.21 | 0.047 | AICAR transformylase inhibitor | 0.046 0.028 DBMET01195 0.047 0.026 DBMET01630 | DBMET01630 | |
| 0.088 | 0.282 | 0.266 | Calpain inhibitor | 0.254 0.061 DBMET01195 0.266 0.051 DBMET01630 | DBMET01630 | |
| 0.015 | 0.209 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 DBMET01195 | DBMET01195 | |
| 0.021 | 0.215 | 0.063 | Androgen agonist | 0.063 0.038 DBMET01195 | DBMET01195 | |
| 0.014 | 0.209 | 0.038 | Estrogen-related receptor beta antagonist | 0.038 0.013 DBMET01194 0.038 0.013 DBMET01196 | DBMET01196 | |
| 0.027 | 0.223 | 0.114 | Cathepsin G inhibitor | 0.114 0.029 DBMET01195 0.085 0.04 DBMET01630 | DBMET01195 | |
| 0.035 | 0.231 | 0.111 | Urease inhibitor | 0.111 0.055 DBMET01195 | DBMET01195 | |
| 0.015 | 0.213 | 0.031 | Glutamate (mGluR4) agonist | 0.031 0.029 DBMET01195 | DBMET01195 | |
| 0.073 | 0.271 | 0.152 | Hepatoprotectant | 0.152 0.108 DBMET01630 | DBMET01630 | |
| 0.044 | 0.243 | 0.177 | Protein kinase C gamma inhibitor | 0.107 0.066 DBMET01193 0.177 0.02 DBMET01195 0.124 0.049 DBMET01631 | DBMET01195 | |
| 0.01 | 0.21 | 0.058 | Glutamate (mGluR group I) agonist | 0.058 0.024 DBMET01195 | DBMET01195 | |
| 0.011 | 0.211 | 0.057 | Prostaglandin EP2 antagonist | 0.057 0.044 DBMET01630 | DBMET01630 | |
| 0.009 | 0.21 | 0.087 | Carbonic anhydrase inhibitor | 0.087 0.032 DBMET01195 | DBMET01195 | |
| 0.028 | 0.229 | 0.056 | Glucosylceramidase inhibitor | 0.051 0.046 DBMET01193 0.056 0.037 DBMET01195 | DBMET01195 | |
| 0.04 | 0.244 | 0.107 | Chelator | 0.107 0.068 DBMET01194 0.107 0.068 DBMET01196 0.106 0.069 DBMET01631 | DBMET01196 | |
| 0.014 | 0.218 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 DBMET01195 | DBMET01195 | |
| 0.04 | 0.244 | 0.141 | Nitric-oxide synthase inhibitor | 0.133 0.031 DBMET01195 0.141 0.026 DBMET01630 0.103 0.055 DBMET01631 | DBMET01630 | |
| 0.042 | 0.246 | 0.106 | Protein kinase C zeta inhibitor | 0.094 0.059 DBMET01193 0.106 0.044 DBMET01195 0.093 0.06 DBMET01631 | DBMET01195 | |
| 0.036 | 0.241 | 0.119 | Gastric antisecretory | 0.119 0.044 DBMET01195 0.093 0.075 DBMET01631 | DBMET01195 | |
| 0.023 | 0.229 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.019 DBMET01195 | DBMET01195 | |
| 0.021 | 0.229 | 0.094 | Cyclin D1 inhibitor | 0.063 0.037 DBMET01193 0.094 0.01 DBMET01195 0.09 0.011 DBMET01630 0.066 0.034 DBMET01631 | DBMET01195 | |
| 0.015 | 0.224 | 0.039 | Tryptophan 5 hydroxylase inhibitor | 0.039 0.017 DBMET01195 | DBMET01195 | |
| 0.042 | 0.254 | 0.211 | Estrogen receptor beta antagonist | 0.139 0.019 DBMET01194 0.211 0.009 DBMET01195 0.139 0.019 DBMET01196 | DBMET01195 | |
| 0.098 | 0.311 | 0.392 | Calpain 2 inhibitor | 0.213 0.177 DBMET01193 0.392 0.065 DBMET01195 0.322 0.101 DBMET01630 | DBMET01195 | |
| 0.006 | 0.22 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.02 DBMET01195 | DBMET01195 | |
| 0.014 | 0.231 | 0.08 | Glutamate (mGluR1a) antagonist | 0.08 0.008 DBMET01195 | DBMET01195 | |
| 0.01 | 0.228 | 0.05 | Integrin alpha2beta1 antagonist | 0.05 0.004 DBMET01195 | DBMET01195 | |
| 0.009 | 0.228 | 0.066 | 5 Hydroxytryptamine 2 agonist | 0.066 0.021 DBMET01193 0.056 0.032 DBMET01631 | DBMET01193 | |
| 0.014 | 0.233 | 0.073 | Plasminogen activator inhibitor | 0.073 0.03 DBMET01630 | DBMET01630 | |
| 0.009 | 0.229 | 0.047 | Phosphorylase inhibitor | 0.047 0.032 DBMET01630 | DBMET01630 | |
| 0.014 | 0.234 | 0.049 | Dihydroorotase inhibitor | 0.049 0.025 DBMET01195 | DBMET01195 | |
| 0.034 | 0.255 | 0.098 | Caspase 7 inhibitor | 0.098 0.03 DBMET01195 | DBMET01195 | |
| 0.088 | 0.31 | 0.232 | DNA damaging | 0.232 0.092 DBMET01195 0.215 0.104 DBMET01631 | DBMET01195 | |
| 0.004 | 0.226 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.022 0.019 DBMET01195 | DBMET01195 | |
| 0.04 | 0.264 | 0.103 | GABA B receptor agonist | 0.076 0.051 DBMET01193 0.103 0.014 DBMET01195 | DBMET01195 | |
| 0.114 | 0.339 | 0.175 | Peptidyltransferase inhibitor | 0.172 0.142 DBMET01194 0.172 0.142 DBMET01196 0.175 0.137 DBMET01630 | DBMET01630 | |
| 0.006 | 0.232 | 0.042 | Free fatty acid receptor 1 antagonist | 0.042 0.014 DBMET01195 | DBMET01195 | |
| 0.011 | 0.238 | 0.093 | Leukocyte elastase inhibitor | 0.093 0.01 DBMET01195 | DBMET01195 | |
| 0.011 | 0.239 | 0.144 | Aldose reductase inhibitor | 0.061 0.031 DBMET01195 0.144 0.011 DBMET01630 | DBMET01630 | |
| 0.068 | 0.296 | 0.151 | Sphingosine 1-phosphate receptor 2 antagonist | 0.151 0.04 DBMET01195 | DBMET01195 | |
| 0.01 | 0.239 | 0.036 | Angiotensin II receptor antagonist | 0.036 0.021 DBMET01195 | DBMET01195 | |
| 0.007 | 0.237 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 DBMET01195 | DBMET01195 | |
| 0.013 | 0.243 | 0.028 | Glucosylceramidase stimulant | 0.028 0.016 DBMET01195 | DBMET01195 | |
| 0.033 | 0.263 | 0.097 | Peroxisome proliferator-activated receptor gamma antagonist | 0.097 0.017 DBMET01195 | DBMET01195 | |
| 0.042 | 0.273 | 0.143 | Caspase 3 inhibitor | 0.124 0.054 DBMET01195 0.143 0.033 DBMET01630 | DBMET01630 | |
| 0.032 | 0.263 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET01195 | DBMET01195 | |
| 0.003 | 0.235 | 0.021 | Nicotinic acid receptor 1 antagonist | 0.021 0.008 DBMET01195 | DBMET01195 | |
| 0.011 | 0.244 | 0.08 | Adenosine A1 receptor antagonist | 0.08 0.028 DBMET01195 | DBMET01195 | |
| 0.022 | 0.255 | 0.055 | Topoisomerase II beta inhibitor | 0.055 0.026 DBMET01195 | DBMET01195 | |
| 0.027 | 0.262 | 0.086 | Histone deacetylase SIRT1 stimulant | 0.069 0.055 DBMET01195 0.086 0.038 DBMET01631 | DBMET01631 | |
| 0.027 | 0.262 | 0.086 | Histone deacetylase stimulant | 0.069 0.055 DBMET01195 0.086 0.038 DBMET01631 | DBMET01631 | |
| 0.048 | 0.284 | 0.145 | Mcl-1 antagonist | 0.145 0.095 DBMET01195 | DBMET01195 | |
| 0.025 | 0.261 | 0.08 | Acetylcholine agonist | 0.08 0.066 DBMET01631 | DBMET01631 | |
| 0.061 | 0.298 | 0.137 | Cyclin-dependent kinase 8 inhibitor | 0.137 0.094 DBMET01195 0.132 0.1 DBMET01631 | DBMET01195 | |
| 0.04 | 0.278 | 0.135 | Thioredoxin inhibitor | 0.135 0.022 DBMET01195 0.116 0.034 DBMET01630 | DBMET01195 | |
| 0.005 | 0.242 | 0.056 | Kynurenine 3 monooxygenase inhibitor | 0.056 0.005 DBMET01195 | DBMET01195 | |
| 0.019 | 0.258 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.03 DBMET01195 | DBMET01195 | |
| 0.009 | 0.248 | 0.049 | Angiotensin AT1 receptor antagonist | 0.049 0.019 DBMET01195 | DBMET01195 | |
| 0.063 | 0.304 | 0.202 | Hypolipemic | 0.202 0.092 DBMET01195 | DBMET01195 | |
| 0.055 | 0.298 | 0.192 | Diuretic | 0.192 0.047 DBMET01195 | DBMET01195 | |
| 0.002 | 0.248 | 0.026 | Peroxisome proliferator-activated receptor alpha antagonist | 0.026 0.013 DBMET01195 | DBMET01195 | |
| 0.04 | 0.286 | 0.092 | Bromodomain-containing protein 2 inhibitor | 0.088 0.06 DBMET01193 0.092 0.051 DBMET01195 | DBMET01195 | |
| 0.007 | 0.253 | 0.291 | Beta tubulin antagonist | 0.291 0.005 DBMET01195 0.055 0.043 DBMET01630 | DBMET01195 | |
| 0.064 | 0.31 | 0.211 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.211 0.094 DBMET01195 | DBMET01195 | |
| 0.022 | 0.269 | 0.076 | Epoxide hydrolase inhibitor | 0.076 0.046 DBMET01195 | DBMET01195 | |
| 0.004 | 0.252 | 0.061 | Carbonic anhydrase IX inhibitor | 0.061 0.037 DBMET01195 | DBMET01195 | |
| 0.147 | 0.396 | 0.33 | MAP kinase kinase 6 inhibitor | 0.33 0.109 DBMET01631 | DBMET01631 | |
| 0.012 | 0.262 | 0.065 | Integrin alpha2 antagonist | 0.065 0.006 DBMET01195 | DBMET01195 | |
| 0.011 | 0.262 | 0.164 | Xanthine dehydrogenase inhibitor | 0.06 0.038 DBMET01195 0.164 0.006 DBMET01630 | DBMET01630 | |
| 0.016 | 0.267 | 0.04 | Glutamate (mGluR group III) agonist | 0.04 0.033 DBMET01195 | DBMET01195 | |
| 0.026 | 0.278 | 0.238 | Alcohol dehydrogenase inhibitor | 0.238 0.009 DBMET01195 0.12 0.035 DBMET01630 | DBMET01195 | |
| 0.011 | 0.264 | 0.08 | Cannabinoid receptor agonist | 0.08 0.035 DBMET01195 | DBMET01195 | |
| 0.03 | 0.284 | 0.069 | Orexin receptor 1 antagonist | 0.069 0.058 DBMET01195 | DBMET01195 | |
| 0.005 | 0.259 | 0.018 | CDK2/cyclin A3 inhibitor | 0.018 0.008 DBMET01195 | DBMET01195 | |
| 0.022 | 0.276 | 0.111 | Potassium channel (ATP-sensitive) blocker | 0.111 0.011 DBMET01195 | DBMET01195 | |
| 0.071 | 0.326 | 0.289 | Prostaglandin dehydrogenase inhibitor | 0.289 0.107 DBMET01195 | DBMET01195 | |
| 0.022 | 0.277 | 0.064 | Beta adrenoreceptor antagonist | 0.064 0.048 DBMET01195 | DBMET01195 | |
| 0.063 | 0.319 | 0.112 | Interleukin 2 antagonist | 0.112 0.06 DBMET01631 | DBMET01631 | |
| 0.017 | 0.274 | 0.135 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.135 0.006 DBMET01195 | DBMET01195 | |
| 0.037 | 0.296 | 0.115 | Alkaline phosphatase inhibitor | 0.115 0.092 DBMET01195 | DBMET01195 | |
| 0.094 | 0.353 | 0.269 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.269 0.035 DBMET01195 0.151 0.148 DBMET01630 | DBMET01195 | |
| 0.015 | 0.276 | 0.073 | Cholesterol esterase inhibitor | 0.073 0.009 DBMET01195 | DBMET01195 | |
| 0.015 | 0.275 | 0.074 | Amidase inhibitor | 0.074 0.043 DBMET01195 0.066 0.056 DBMET01630 | DBMET01195 | |
| 0.005 | 0.266 | 0.037 | Vascular adhesion protein 1 inhibitor | 0.037 0.029 DBMET01193 | DBMET01193 | |
| 0.037 | 0.301 | 0.164 | Xanthine oxidase inhibitor | 0.164 0.029 DBMET01195 0.11 0.053 DBMET01630 | DBMET01195 | |
| 0.058 | 0.323 | 0.262 | Hexokinase inhibitor | 0.262 0.015 DBMET01195 0.177 0.052 DBMET01630 | DBMET01195 | |
| 0.011 | 0.277 | 0.131 | HIV-1 integrase (Strand Transfer) inhibitor | 0.131 0.015 DBMET01630 | DBMET01630 | |
| 0.037 | 0.303 | 0.126 | Bile acid receptor antagonist | 0.126 0.015 DBMET01195 | DBMET01195 | |
| 0.004 | 0.271 | 0.06 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.06 0.005 DBMET01195 | DBMET01195 | |
| 0.035 | 0.306 | 0.111 | GABA receptor agonist | 0.111 0.065 DBMET01195 | DBMET01195 | |
| 0.009 | 0.281 | 0.058 | Cathepsin L inhibitor | 0.058 0.041 DBMET01195 0.051 0.049 DBMET01630 | DBMET01195 | |
| 0.005 | 0.28 | 0.028 | CC chemokine 9 receptor antagonist | 0.028 0.004 DBMET01195 | DBMET01195 | |
| 0.006 | 0.283 | 0.055 | Liver X receptor beta antagonist | 0.055 0.007 DBMET01195 | DBMET01195 | |
| 0.006 | 0.284 | 0.045 | Dihydropteroate synthase inhibitor | 0.045 0.021 DBMET01195 | DBMET01195 | |
| 0.006 | 0.285 | 0.064 | Estrogen agonist | 0.054 0.033 DBMET01194 0.064 0.028 DBMET01195 0.054 0.033 DBMET01196 | DBMET01195 | |
| 0.083 | 0.364 | 0.239 | Histone acetyltransferase inhibitor | 0.239 0.03 DBMET01195 | DBMET01195 | |
| 0.02 | 0.302 | 0.077 | Fatty acid synthase inhibitor | 0.077 0.02 DBMET01195 | DBMET01195 | |
| 0.066 | 0.351 | 0.137 | MAP kinase 3 inhibitor | 0.137 0.09 DBMET01195 | DBMET01195 | |
| 0.015 | 0.301 | 0.09 | HIV-1 reverse transcriptase inhibitor | 0.09 0.036 DBMET01195 | DBMET01195 | |
| 0.012 | 0.3 | 0.047 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.027 DBMET01193 | DBMET01193 | |
| 0.028 | 0.317 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 DBMET01195 | DBMET01195 | |
| 0.027 | 0.318 | 0.064 | Telomerase inhibitor | 0.064 0.059 DBMET01631 | DBMET01631 | |
| 0.009 | 0.3 | 0.243 | 5 Hydroxytryptamine agonist | 0.204 0.014 DBMET01193 0.243 0.011 DBMET01631 | DBMET01631 | |
| 0.041 | 0.333 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.129 0.086 DBMET01193 0.119 0.098 DBMET01631 | DBMET01193 | |
| 0.004 | 0.302 | 0.037 | Cathepsin L1 inhibitor | 0.037 0.029 DBMET01195 | DBMET01195 | |
| 0.009 | 0.307 | 0.046 | Glutamate (mGluR3) antagonist | 0.046 0.015 DBMET01195 | DBMET01195 | |
| 0.005 | 0.307 | 0.046 | Fructose-1,6-bisphosphatase inhibitor | 0.046 0.029 DBMET01195 | DBMET01195 | |
| 0.004 | 0.311 | 0.057 | Carbonic anhydrase IV inhibitor | 0.057 0.02 DBMET01195 | DBMET01195 | |
| 0.04 | 0.348 | 0.171 | ABCA1 expression enhancer | 0.109 0.04 DBMET01195 0.171 0.013 DBMET01630 | DBMET01630 | |
| 0.043 | 0.351 | 0.186 | I kappa B kinase epsilon inhibitor | 0.153 0.116 DBMET01193 0.186 0.083 DBMET01195 0.166 0.103 DBMET01631 | DBMET01195 | |
| 0.015 | 0.326 | 0.058 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.042 DBMET01195 | DBMET01195 | |
| 0.013 | 0.329 | 0.048 | H+/K+-transporting ATPase inhibitor | 0.048 0.04 DBMET01630 | DBMET01630 | |
| 0.051 | 0.368 | 0.175 | Antiamyloidogenic | 0.175 0.118 DBMET01195 | DBMET01195 | |
| 0.034 | 0.352 | 0.154 | Falcipain inhibitor | 0.154 0.029 DBMET01630 | DBMET01630 | |
| 0.005 | 0.323 | 0.061 | Liver X receptor beta agonist | 0.061 0.008 DBMET01195 | DBMET01195 | |
| 0.016 | 0.334 | 0.052 | Purinergic P2X4 antagonist | 0.051 0.024 DBMET01193 0.052 0.022 DBMET01195 | DBMET01195 | |
| 0.007 | 0.327 | 0.034 | Nicotinic acid receptor agonist | 0.034 0.028 DBMET01195 | DBMET01195 | |
| 0.011 | 0.332 | 0.123 | Benzodiazepine agonist | 0.123 0.015 DBMET01195 | DBMET01195 | |
| 0.033 | 0.36 | 0.125 | Falcipain 2 inhibitor | 0.125 0.04 DBMET01630 | DBMET01630 | |
| 0.01 | 0.337 | 0.151 | Peroxisome proliferator-activated receptor gamma agonist | 0.151 0.013 DBMET01195 | DBMET01195 | |
| 0.007 | 0.336 | 0.042 | Thymidylate synthase inhibitor | 0.042 0.039 DBMET01195 | DBMET01195 | |
| 0.045 | 0.374 | 0.312 | 3C-Like protease (SARS coronavirus) inhibitor | 0.312 0.003 DBMET01630 | DBMET01630 | |
| 0.011 | 0.341 | 0.048 | Benzodiazepine antagonist | 0.048 0.032 DBMET01195 | DBMET01195 | |
| 0.011 | 0.342 | 0.055 | Cyclin A1 inhibitor | 0.055 0.05 DBMET01193 | DBMET01193 | |
| 0.013 | 0.348 | 0.043 | GABA B receptor antagonist | 0.043 0.029 DBMET01195 | DBMET01195 | |
| 0.026 | 0.37 | 0.071 | Phosphodiesterase 1C inhibitor | 0.071 0.028 DBMET01195 | DBMET01195 | |
| 0.027 | 0.371 | 0.08 | Chymotrypsin inhibitor | 0.08 0.055 DBMET01630 | DBMET01630 | |
| 0.015 | 0.363 | 0.091 | MAP kinase kinase kinase inhibitor | 0.091 0.075 DBMET01195 | DBMET01195 | |
| 0.015 | 0.366 | 0.057 | Human rhinovirus A protease inhibitor | 0.057 0.037 DBMET01630 | DBMET01630 | |
| 0.13 | 0.481 | 0.233 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.214 0.129 DBMET01193 0.233 0.09 DBMET01631 | DBMET01631 | |
| 0.016 | 0.368 | 0.074 | Aldosterone antagonist | 0.074 0.013 DBMET01195 | DBMET01195 | |
| 0.027 | 0.38 | 0.108 | Interleukin 1 beta converting enzyme inhibitor | 0.108 0.048 DBMET01195 0.096 0.063 DBMET01630 | DBMET01195 | |
| 0.038 | 0.394 | 0.203 | Interleukin 8 antagonist | 0.203 0.012 DBMET01195 | DBMET01195 | |
| 0.009 | 0.366 | 0.073 | Liver X receptor alpha agonist | 0.073 0.008 DBMET01195 | DBMET01195 | |
| 0.012 | 0.37 | 0.052 | Phenylethanolamine N methyltransferase inhibitor | 0.052 0.013 DBMET01193 0.042 0.025 DBMET01631 | DBMET01193 | |
| 0.005 | 0.364 | 0.05 | Elastase 2A inhibitor | 0.05 0.005 DBMET01195 | DBMET01195 | |
| 0.005 | 0.364 | 0.05 | Elastase 2 inhibitor | 0.05 0.005 DBMET01195 | DBMET01195 | |
| 0.008 | 0.368 | 0.064 | Neutrophil collagenase inhibitor | 0.064 0.046 DBMET01195 | DBMET01195 | |
| 0.021 | 0.386 | 0.06 | Phosphodiesterase 1B inhibitor | 0.06 0.042 DBMET01195 | DBMET01195 | |
| 0.017 | 0.383 | 0.056 | MAP kinase kinase 9 inhibitor | 0.056 0.039 DBMET01195 | DBMET01195 | |
| 0.006 | 0.373 | 0.038 | CDK5/p25 inhibitor | 0.038 0.032 DBMET01195 | DBMET01195 | |
| 0.017 | 0.389 | 0.188 | Elastase 1 inhibitor | 0.188 0.004 DBMET01195 0.117 0.013 DBMET01630 | DBMET01195 | |
| 0.058 | 0.43 | 0.159 | Focal adhesion kinase 2 inhibitor | 0.159 0.116 DBMET01195 | DBMET01195 | |
| 0.01 | 0.383 | 0.06 | MAP3K5 inhibitor | 0.06 0.005 DBMET01195 | DBMET01195 | |
| 0.006 | 0.381 | 0.031 | Thyroid hormone agonist | 0.031 0.011 DBMET01195 | DBMET01195 | |
| 0.02 | 0.399 | 0.109 | Potassium channel (Ca-activated) activator | 0.109 0.049 DBMET01195 | DBMET01195 | |
| 0.054 | 0.434 | 0.252 | Thyroid hormone beta antagonist | 0.252 0.117 DBMET01195 | DBMET01195 | |
| 0.013 | 0.402 | 0.079 | Potassium channel (ATP-sensitive) activator | 0.079 0.007 DBMET01195 | DBMET01195 | |
| 0.013 | 0.405 | 0.082 | Potassium channel (Inward rectifier) activator | 0.082 0.007 DBMET01195 | DBMET01195 | |
| 0.018 | 0.411 | 0.134 | MAP kinase kinase inhibitor | 0.134 0.062 DBMET01195 | DBMET01195 | |
| 0.025 | 0.419 | 0.335 | Aryl hydrocarbon receptor agonist | 0.335 0.051 DBMET01195 | DBMET01195 | |
| 0.019 | 0.414 | 0.089 | Protease inhibitor | 0.089 0.076 DBMET01630 | DBMET01630 | |
| 0.008 | 0.404 | 0.057 | Stearoyl-CoA desaturase inhibitor | 0.057 0.019 DBMET01195 | DBMET01195 | |
| 0.003 | 0.4 | 0.088 | Urate transporter 1 inhibitor | 0.088 0.006 DBMET01195 | DBMET01195 | |
| 0.004 | 0.402 | 0.049 | Cyclin E2 inhibitor | 0.049 0.009 DBMET01195 | DBMET01195 | |
| 0.027 | 0.43 | 0.109 | DNA directed RNA polymerase inhibitor | 0.109 0.047 DBMET01195 | DBMET01195 | |
| 0.039 | 0.442 | 0.213 | Platelet aggregation inhibitor | 0.213 0.073 DBMET01195 | DBMET01195 | |
| 0.049 | 0.453 | 0.258 | Thyroid hormone antagonist | 0.258 0.119 DBMET01195 | DBMET01195 | |
| 0.012 | 0.419 | 0.078 | Leukotriene synthesis inhibitor | 0.078 0.039 DBMET01195 | DBMET01195 | |
| 0.026 | 0.436 | 0.22 | MAP kinase kinase 2 inhibitor | 0.22 0.07 DBMET01195 | DBMET01195 | |
| 0.027 | 0.437 | 0.084 | Phosphodiesterase I inhibitor | 0.084 0.07 DBMET01195 | DBMET01195 | |
| 0.006 | 0.419 | 0.063 | Nicotinic receptor alpha4 subunit antagonist | 0.063 0.02 DBMET01193 0.06 0.022 DBMET01631 | DBMET01193 | |
| 0.015 | 0.428 | 0.066 | Heat shock protein 90 beta antagonist | 0.066 0.032 DBMET01195 | DBMET01195 | |
| 0.016 | 0.43 | 0.123 | Transcription factor AP-1 inhibitor | 0.123 0.009 DBMET01195 0.056 0.052 DBMET01630 | DBMET01195 | |
| 0.017 | 0.438 | 0.116 | Potassium channel activator | 0.116 0.035 DBMET01195 | DBMET01195 | |
| 0.014 | 0.439 | 0.054 | 5 Hydroxytryptamine 1B agonist | 0.054 0.035 DBMET01193 0.05 0.043 DBMET01631 | DBMET01193 | |
| 0.025 | 0.465 | 0.126 | Beta amyloid protein antagonist | 0.126 0.061 DBMET01195 | DBMET01195 | |
| 0.017 | 0.458 | 0.168 | LIM domain kinase 1 inhibitor | 0.168 0.082 DBMET01195 | DBMET01195 | |
| 0.004 | 0.448 | 0.062 | Cannabinoid CB2 receptor agonist | 0.062 0.033 DBMET01195 | DBMET01195 | |
| 0.004 | 0.449 | 0.102 | Glutamate (mGluR1) antagonist | 0.102 0.015 DBMET01195 | DBMET01195 | |
| 0.003 | 0.453 | 0.026 | CXC chemokine 2 receptor antagonist | 0.026 0.019 DBMET01195 | DBMET01195 | |
| 0.005 | 0.462 | 0.088 | Prostaglandin-E synthase inhibitor | 0.088 0.034 DBMET01195 | DBMET01195 | |
| 0.009 | 0.468 | 0.131 | CDC25B inhibitor | 0.131 0.009 DBMET01195 0.1 0.016 DBMET01630 | DBMET01195 | |
| 0.033 | 0.511 | 0.14 | Hemostatic | 0.14 0.081 DBMET01195 | DBMET01195 | |
| 0.006 | 0.499 | 0.492 | CDK4/cyclin D1 inhibitor | 0.088 0.02 DBMET01195 0.492 0.003 DBMET01630 0.062 0.037 DBMET01631 | DBMET01630 | |
| 0.008 | 0.508 | 0.05 | Diacylglycerol O-acyltransferase inhibitor | 0.05 0.036 DBMET01195 | DBMET01195 | |
| 0.059 | 0.563 | 0.123 | Death-associated protein kinase 1 inhibitor | 0.123 0.104 DBMET01631 | DBMET01631 | |
| 0.062 | 0.566 | 0.297 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.297 0.066 DBMET01631 | DBMET01631 | |
| 0.006 | 0.532 | 0.046 | Estrogen-related receptor alpha antagonist | 0.046 0.015 DBMET01195 | DBMET01195 | |
| 0.025 | 0.558 | 0.274 | Amyloid beta precursor protein antagonist | 0.274 0.024 DBMET01630 | DBMET01630 | |
| 0.018 | 0.554 | 0.36 | Cyclooxygenase inhibitor | 0.36 0.01 DBMET01195 | DBMET01195 | |
| 0.022 | 0.558 | 0.502 | Antimitotic | 0.502 0.012 DBMET01195 | DBMET01195 | |
| 0.01 | 0.55 | 0.101 | Elastase 3B inhibitor | 0.101 0.002 DBMET01195 | DBMET01195 | |
| 0.01 | 0.55 | 0.101 | Elastase 2B inhibitor | 0.101 0.002 DBMET01195 | DBMET01195 | |
| 0.01 | 0.55 | 0.101 | Elastase 3A inhibitor | 0.101 0.002 DBMET01195 | DBMET01195 | |
| 0.02 | 0.562 | 0.234 | Angiogenesis stimulant | 0.234 0.077 DBMET01195 | DBMET01195 | |
| 0.012 | 0.56 | 0.073 | Topoisomerase II alpha inhibitor | 0.073 0.058 DBMET01630 | DBMET01630 | |
| 0.015 | 0.565 | 0.06 | Trypsin inhibitor | 0.06 0.048 DBMET01630 | DBMET01630 | |
| 0.01 | 0.576 | 0.136 | Platelet activating factor antagonist | 0.136 0.053 DBMET01195 | DBMET01195 | |
| 0.008 | 0.576 | 0.066 | CXC chemokine 4 receptor antagonist | 0.066 0.039 DBMET01193 | DBMET01193 | |
| 0.073 | 0.642 | 0.445 | Interleukin 2 agonist | 0.445 0.016 DBMET01195 | DBMET01195 | |
| 0.019 | 0.595 | 0.063 | Alpha 1b adrenoreceptor agonist | 0.063 0.016 DBMET01193 0.058 0.021 DBMET01631 | DBMET01193 | |
| 0.008 | 0.595 | 0.12 | HIV-1 integrase inhibitor | 0.064 0.058 DBMET01195 0.12 0.015 DBMET01630 | DBMET01630 | |
| 0.004 | 0.594 | 0.053 | GABA A receptor antagonist | 0.053 0.037 DBMET01195 | DBMET01195 | |
| 0.005 | 0.595 | 0.308 | CDK4/cyclin D inhibitor | 0.093 0.017 DBMET01195 0.308 0.004 DBMET01630 | DBMET01630 | |
| 0.004 | 0.603 | 0.055 | GABA receptor antagonist | 0.055 0.037 DBMET01195 | DBMET01195 | |
| 0.02 | 0.628 | 0.111 | Caspase 9 inhibitor | 0.111 0.011 DBMET01630 | DBMET01630 | |
| 0.008 | 0.622 | 0.149 | CDC25A inhibitor | 0.149 0.013 DBMET01195 | DBMET01195 | |
| 0.022 | 0.644 | 0.125 | Interleukin 5 antagonist | 0.125 0.021 DBMET01630 | DBMET01630 | |
| 0.022 | 0.644 | 0.151 | DNA polymerase I inhibitor | 0.151 0.048 DBMET01195 | DBMET01195 | |
| 0.017 | 0.645 | 0.399 | Interleukin antagonist | 0.399 0.031 DBMET01195 | DBMET01195 | |
| 0.004 | 0.636 | 0.037 | 5 Hydroxytryptamine 1F agonist | 0.037 0.008 DBMET01195 | DBMET01195 | |
| 0.005 | 0.64 | 0.357 | Alpha tubulin antagonist | 0.357 0.004 DBMET01195 | DBMET01195 | |
| 0.047 | 0.694 | 0.635 | Antiinflammatory | 0.385 0.148 DBMET01195 0.635 0.044 DBMET01630 | DBMET01630 | |
| 0.042 | 0.689 | 0.164 | MAP-kinase-activated kinase 5 inhibitor | 0.164 0.158 DBMET01631 | DBMET01631 | |
| 0.005 | 0.663 | 0.074 | Protein kinase C epsilon inhibitor | 0.074 0.022 DBMET01195 | DBMET01195 | |
| 0.008 | 0.675 | 0.081 | Protein 50S ribosomal subunit inhibitor | 0.081 0.019 DBMET01630 | DBMET01630 | |
| 0.028 | 0.71 | 0.114 | Interleukin 12 antagonist | 0.114 0.035 DBMET01195 | DBMET01195 | |
| 0.018 | 0.703 | 0.113 | MAP kinase 7 inhibitor | 0.113 0.004 DBMET01195 | DBMET01195 | |
| 0.003 | 0.692 | 0.17 | Calpain 1 inhibitor | 0.17 0.003 DBMET01630 | DBMET01630 | |
| 0.01 | 0.701 | 0.332 | Dual specificity phosphatase 3 inhibitor | 0.332 0.023 DBMET01195 | DBMET01195 | |
| 0.012 | 0.705 | 0.068 | Alpha 1L adrenoreceptor agonist | 0.068 0.005 DBMET01193 0.057 0.01 DBMET01631 | DBMET01193 | |
| 0.008 | 0.711 | 0.086 | MAP-kinase-activated kinase 2 inhibitor | 0.086 0.038 DBMET01631 | DBMET01631 | |
| 0.009 | 0.714 | 0.098 | MAP-kinase-activated kinase inhibitor | 0.098 0.041 DBMET01631 | DBMET01631 | |
| 0.019 | 0.724 | 0.752 | Platelet adhesion inhibitor | 0.752 0.003 DBMET01630 | DBMET01630 | |
| 0.004 | 0.722 | 0.028 | Motilin receptor agonist | 0.028 0.011 DBMET01193 | DBMET01193 | |
| 0.003 | 0.725 | 0.244 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.244 0.003 DBMET01195 | DBMET01195 | |
| 0.072 | 0.797 | 0.7 | Calcium channel L-type activator | 0.275 0.18 DBMET01193 0.7 0.003 DBMET01195 | DBMET01195 | |
| 0.007 | 0.736 | 0.187 | Platelet growth factor antagonist | 0.187 0.011 DBMET01195 | DBMET01195 | |
| 0.005 | 0.747 | 0.039 | p53 inhibitor | 0.039 0.021 DBMET01195 | DBMET01195 | |
| 0.01 | 0.759 | 0.286 | Dual specificity phosphatase inhibitor | 0.286 0.031 DBMET01195 | DBMET01195 | |
| 0.006 | 0.755 | 0.139 | Cathepsin B inhibitor | 0.139 0.008 DBMET01630 | DBMET01630 | |
| 0.003 | 0.767 | 0.16 | 5 Hydroxytryptamine 2C agonist | 0.16 0.005 DBMET01193 0.109 0.007 DBMET01631 | DBMET01193 | |
| 0.007 | 0.784 | 0.305 | Uric acid excretion stimulant | 0.305 0.005 DBMET01195 0.094 0.059 DBMET01630 | DBMET01195 | |
| 0.032 | 0.811 | 0.365 | MAP kinase kinase 4 inhibitor | 0.365 0.003 DBMET01195 | DBMET01195 | |
| 0.009 | 0.791 | 0.148 | Autotaxin inhibitor | 0.148 0.008 DBMET01195 | DBMET01195 | |
| 0.004 | 0.788 | 0.11 | Protein kinase C alpha inhibitor | 0.11 0.019 DBMET01195 0.062 0.056 DBMET01631 | DBMET01195 | |
| 0.005 | 0.796 | 0.086 | Lipase inhibitor | 0.086 0.037 DBMET01630 | DBMET01630 | |
| 0.004 | 0.796 | 0.05 | Plasmin inhibitor | 0.05 0.032 DBMET01630 | DBMET01630 | |
| 0.005 | 0.812 | 0.204 | Cyclooxygenase 2 inhibitor | 0.204 0.03 DBMET01195 | DBMET01195 | |
| 0.007 | 0.832 | 0.087 | Potassium channel (Ca-activated) blocker | 0.087 0.014 DBMET01195 | DBMET01195 | |
| 0.005 | 0.832 | 0.11 | Stem cell growth factor agonist | 0.11 0.037 DBMET01195 | DBMET01195 | |
| 0.009 | 0.84 | 0.203 | MAP kinase 13 inhibitor | 0.203 0.02 DBMET01195 | DBMET01195 | |
| 0.017 | 0.853 | 0.119 | Interleukin 4 antagonist | 0.119 0.086 DBMET01195 | DBMET01195 | |
| 0.01 | 0.847 | 0.501 | Angiogenesis inhibitor | 0.501 0.029 DBMET01630 | DBMET01630 | |
| 0.007 | 0.861 | 0.201 | MAP kinase 12 inhibitor | 0.201 0.022 DBMET01195 | DBMET01195 | |
| 0.004 | 0.861 | 0.175 | Check point kinase 2 inhibitor | 0.175 0.024 DBMET01195 | DBMET01195 | |
| 0.003 | 0.861 | 0.034 | Liver X receptor alpha antagonist | 0.034 0.014 DBMET01195 | DBMET01195 | |
| 0.027 | 0.889 | 0.277 | Factor V inhibitor | 0.277 0.002 DBMET01630 | DBMET01630 | |
| 0.004 | 0.872 | 0.199 | CDK/cyclin complex inhibitor | 0.078 0.071 DBMET01195 0.199 0.019 DBMET01630 | DBMET01630 | |
| 0.003 | 0.881 | 0.098 | CDK2/cyclin E inhibitor | 0.098 0.023 DBMET01195 | DBMET01195 | |
| 0 | 0.884 | 0.014 | Insulin like growth factor 3 antagonist | 0.014 0.002 DBMET01195 | DBMET01195 | |
| 0.005 | 0.89 | 0.134 | Protein kinase C mu inhibitor | 0.134 0.034 DBMET01193 | DBMET01193 | |
| 0.009 | 0.897 | 0.311 | Farnesoid X receptor antagonist | 0.311 0.005 DBMET01195 | DBMET01195 | |
| 0.003 | 0.895 | 0.031 | Liver X receptor antagonist | 0.031 0.022 DBMET01195 | DBMET01195 | |
| 0.005 | 0.901 | 0.193 | MAP kinase 11 inhibitor | 0.193 0.01 DBMET01195 | DBMET01195 | |
| 0.004 | 0.901 | 0.103 | MAP kinase 14 inhibitor | 0.103 0.034 DBMET01195 | DBMET01195 | |
| 0.003 | 0.902 | 0.061 | Cyclin E inhibitor | 0.061 0.041 DBMET01195 | DBMET01195 | |
| 0.007 | 0.91 | 0.095 | Factor XII inhibitor | 0.095 0.043 DBMET01630 | DBMET01630 | |
| 0.004 | 0.911 | 0.058 | Elastase inhibitor | 0.058 0.032 DBMET01195 | DBMET01195 | |
| 0.003 | 0.912 | 0.058 | Liver X receptor agonist | 0.058 0.018 DBMET01195 | DBMET01195 | |
| 0.008 | 0.919 | 0.199 | Interleukin 6 antagonist | 0.199 0.041 DBMET01195 | DBMET01195 | |
| 0.002 | 0.917 | 0.058 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.058 0.001 DBMET01195 | DBMET01195 | |
| 0.004 | 0.919 | 0.167 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.167 0.061 DBMET01195 | DBMET01195 | |
| 0.004 | 0.924 | 0.151 | CDC-like kinase 1 inhibitor | 0.151 0.069 DBMET01195 | DBMET01195 | |
| 0.003 | 0.925 | 0.102 | Cyclin B2 inhibitor | 0.102 0.009 DBMET01195 | DBMET01195 | |
| 0.003 | 0.928 | 0.088 | Cyclin B inhibitor | 0.088 0.013 DBMET01195 | DBMET01195 | |
| 0.004 | 0.93 | 0.087 | Protein kinase A inhibitor | 0.087 0.054 DBMET01195 | DBMET01195 | |
| 0.003 | 0.933 | 0.104 | Cyclin B1 inhibitor | 0.104 0.01 DBMET01195 | DBMET01195 | |
| 0.004 | 0.936 | 0.409 | p38 MAP kinase inhibitor | 0.409 0.005 DBMET01195 | DBMET01195 | |
| 0.007 | 0.943 | 0.047 | CXC chemokine 1 receptor antagonist | 0.047 0.045 DBMET01195 | DBMET01195 | |
| 0.005 | 0.942 | 0.361 | Bone formation stimulant | 0.126 0.08 DBMET01195 0.361 0.012 DBMET01630 | DBMET01630 | |
| 0.002 | 0.941 | 0.056 | Peroxisome proliferator-activated receptor delta antagonist | 0.056 0.008 DBMET01195 | DBMET01195 | |
| 0.004 | 0.945 | 0.15 | Cyclin B3 inhibitor | 0.15 0.013 DBMET01195 | DBMET01195 | |
| 0.003 | 0.944 | 0.105 | Cyclin-dependent kinase 1 inhibitor | 0.105 0.063 DBMET01195 | DBMET01195 | |
| 0.003 | 0.945 | 0.097 | CDK1/cyclin B inhibitor | 0.097 0.026 DBMET01195 | DBMET01195 | |
| 0.01 | 0.968 | 0.263 | Growth factor agonist | 0.263 0.026 DBMET01195 | DBMET01195 | |
| 0.002 | 0.965 | 0.023 | Potassium channel (Inward rectifier) 11 blocker | 0.023 0.006 DBMET01195 | DBMET01195 | |
| 0.002 | 0.966 | 0.204 | Raf kinase C inhibitor | 0.204 0.009 DBMET01195 | DBMET01195 | |
| 0.004 | 0.972 | 0.089 | Hedgehog signaling inhibitor | 0.089 0.088 DBMET01195 | DBMET01195 | |
| 0.001 | 0.995 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.015 DBMET01195 | DBMET01195 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |